{
  "meta": {
    "title": "00100_Late_Night_Pyq_Pyt_Marathon_Medicine-10",
    "url": "https://brainandscalpel.vercel.app/00100-late-night-pyq-pyt-marathon-medicine-10-f5954875.html",
    "scrapedAt": "2025-11-29T17:25:57.031Z"
  },
  "questions": [
    {
      "id": 51954,
      "choices": [
        {
          "id": 207329,
          "text": "<p><span style=\"font-size:12.0pt;\">Diameter of the main pulmonary artery &gt; 16 mm</span></p>"
        },
        {
          "id": 207330,
          "text": "<p><span style=\"font-size:12.0pt;\">Diameter of the left pulmonary artery &gt; 16 mm</span></p>"
        },
        {
          "id": 207331,
          "text": "<p><span style=\"font-size:12.0pt;\">Diameter of the descending right pulmonary artery &gt; 16 mm</span></p>"
        },
        {
          "id": 207332,
          "text": "<p><span style=\"font-size:12.0pt;\">Diameter of the descending left pulmonary artery &gt; 16 mm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the objective sign of identifying pulmonary plethora in a chest radiograph? (NEET PG 2014)</span></p>",
      "unique_key": "Q5534703",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290243,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)</strong></span><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Diameter of the descending right pulmonary artery &gt; 16 mm</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pulmonary plethora refers to an increased blood flow to the lungs, which can be identified on a chest radiograph. One objective sign of pulmonary plethora is the measurement of the diameter of the descending right pulmonary artery. If the diameter exceeds 16 mm, it is indicative of increased pulmonary blood flow, suggesting pulmonary plethora.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The descending right pulmonary artery is a key structure evaluated in chest radiographs when assessing for signs of pulmonary congestion or increased blood flow. Measurements greater than 16 mm suggest that the pulmonary vascular system is under increased pressure or volume, which is a hallmark of pulmonary plethora.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>A</strong>. <strong>Diameter of the main pulmonary artery &gt; 16 mm:</strong> While the main pulmonary artery's diameter is relevant in assessing overall pulmonary artery pressure, it is not as specific for identifying pulmonary plethora as the descending right pulmonary artery.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>B</strong>. <strong>Diameter of the left pulmonary artery &gt; 16 mm:</strong> The left pulmonary artery's diameter is not typically used as a specific indicator for pulmonary plethora on a chest radiograph.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>D</strong>. <strong>Diameter of the descending left pulmonary artery &gt; 16 mm:</strong> The descending left pulmonary artery is not the standard measurement used to identify pulmonary plethora; the descending right pulmonary artery is preferred for this assessment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The objective sign of identifying pulmonary plethora in a chest radiograph is a diameter of the descending right pulmonary artery greater than 16 mm.</span></p>",
      "correct_choice_id": 207331,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11209,
      "choices": [
        {
          "id": 44802,
          "text": "<p><span style=\"font-size:12.0pt;\">7.5 years</span></p>"
        },
        {
          "id": 44803,
          "text": "<p><span style=\"font-size:12.0pt;\">10 years</span></p>"
        },
        {
          "id": 44804,
          "text": "<p><span style=\"font-size:12.0pt;\">12 years</span></p>"
        },
        {
          "id": 44805,
          "text": "<p><span style=\"font-size:12.0pt;\">5 years</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the approximate time interval between HIV infection &amp; manifestation of AIDS? (NEET PG 2018)</span></p>",
      "unique_key": "Q2225403",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290244,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 10 years</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The typical time interval from HIV infection to the manifestation of AIDS, in the absence of antiretroviral therapy, is approximately 10 years. This period is often referred to as the latency period, during which the virus is actively replicating in the body, but the immune system has not yet deteriorated to the point of clinical AIDS. This period can vary based on several factors, including the individual's genetic predisposition, co-infections, and overall health.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mean interval b/w infection to AIDS is due to prolonged latency period (~10- years).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/HIV/Chap 201</strong></span></p>",
      "correct_choice_id": 44803,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47517,
      "choices": [
        {
          "id": 189679,
          "text": "<p><span style=\"font-size:12.0pt;\">Age</span></p>"
        },
        {
          "id": 189680,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertension</span></p>"
        },
        {
          "id": 189681,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes mellitus</span></p>"
        },
        {
          "id": 189682,
          "text": "<p><span style=\"font-size:12.0pt;\">History of stroke</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following factors is not included in ABCD2 scoring?&nbsp;</span>(FMGE JULY 2023)</p>",
      "unique_key": "Q5988488",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290245,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) History of stroke</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ABCD2 score is used to assess the risk of developing a subsequent stroke following a transient ischemic attack (TIA).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The components of the ABCD2 score include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>A (Age):&nbsp;</strong>Age 60 years or older scores 1 point.</span></li><li><span style=\"font-size:12.0pt;\"><strong>B (Blood Pressure):&nbsp;</strong>Systolic blood pressure of 140 mm Hg or higher, or diastolic blood pressure of 90 mm Hg or higher scores 1 point.</span></li><li><span style=\"font-size:12.0pt;\"><strong>C (Clinical Features):&nbsp;</strong>Unilateral weakness scores 2 points; speech disturbance without weakness scores 1 point.</span></li><li><span style=\"font-size:12.0pt;\"><strong>D (Diabetes):&nbsp;</strong>Presence of diabetes scores 1 point.</span></li><li><span style=\"font-size:12.0pt;\"><strong>D (Duration of Symptoms):&nbsp;</strong>Symptoms lasting 60 minutes or longer score 2 points; symptoms lasting 10-59 minutes score 1 point.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">History of stroke is not included in the ABCD2 scoring system. Instead, it is a component of other scoring systems, such as the CHADS2 or CHA2DS2-VASc scores, which are used to assess the risk of stroke in patients with atrial fibrillation and to guide anticoagulation therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Age:&nbsp;</strong>Age 60 years or older is a factor in the ABCD2 score and scores 1 point.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hypertension:&nbsp;</strong>Elevated blood pressure is included in the ABCD2 score and scores 1 point.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diabetes mellitus:&nbsp;</strong>The presence of diabetes is included in the ABCD2 score and scores 1 point.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ABCD2 score includes age, blood pressure, clinical features, duration of symptoms, and diabetes. History of stroke is not included in this scoring system but is part of other risk assessment tools like CHADS2 and CHA2DS2-VASc</span></p>",
      "correct_choice_id": 189682,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24778,
      "choices": [
        {
          "id": 99073,
          "text": "<p><span style=\"font-size:11.0pt;\">Vascular disease with bronchodilator reversibility</span></p>"
        },
        {
          "id": 99074,
          "text": "<p><span style=\"font-size:11.0pt;\">Restrictive lung disease with bronchodilator reversibility</span></p>"
        },
        {
          "id": 99075,
          "text": "<p><span style=\"font-size:11.0pt;\">Restrictive lung disease without bronchodilator reversibility</span></p>"
        },
        {
          "id": 99076,
          "text": "<p><span style=\"font-size:11.0pt;\">Obstructive disease with bronchodilator reversibility</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A chronic cigarette smoker now joined a construction company. His pulmonary function test results are given below.(INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Initial lung volumes were: FEV1 - 0.9L, FVC - 1.9L, FEV1/FVC - 0.4</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">After bronchodilation: FEV1 - 1.9L, FVC - 3.9L, FEV1/FVC - 0.4</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">What is the most likely diagnosis for this patient?</span></p>",
      "unique_key": "Q7107803",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290246,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)&nbsp;Obstructive disease with bronchodilator reversibility</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The pulmonary function test results show a reduced FEV1/FVC ratio, consistent with obstructive lung disease. Significant improvement in FEV1 post-bronchodilation indicates reversibility (FEV1 - anything &gt;200ml is significant), suggesting conditions like asthma or COPD with reversible obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:12pt;\"><strong>Option A. Vascular disease with bronchodilator reversibility</strong>: Pulmonary function tests do not suggest vascular disease.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option B. Restrictive lung disease with bronchodilator reversibility:</strong> Restrictive diseases show reduced volumes but normal or increased FEV1/FVC ratio.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option C. Restrictive lung disease without bronchodilator reversibility</strong>: Not applicable as the patient shows obstructive pattern with reversibility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Obstructive lung diseases, such as asthma or COPD, may show bronchodilator reversibility.</span></p>",
      "correct_choice_id": 99076,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11649,
      "choices": [
        {
          "id": 46562,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">FAMMM Syndrome</span></p>"
        },
        {
          "id": 46563,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">FAP</span></p>"
        },
        {
          "id": 46564,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hereditary pancreatitis</span></p>"
        },
        {
          "id": 46565,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Peutz Jegher’s syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Pancreatic cancer has the highest association with:&nbsp;</span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2017)</span></p>",
      "unique_key": "Q1927010",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290247,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) Peutz Jegher’s syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Peutz-Jeghers syndrome (PJS) is significantly associated with an increased risk of pancreatic cancer. PJS is an autosomal dominant disorder characterized by the development of benign polyps in the gastrointestinal tract and distinctive pigmented spots on the skin. It is caused by mutations in the STK11 (LKB1) gene. Individuals with PJS have a markedly increased risk of developing several types of cancer, including a 36% lifetime risk of developing pancreatic cancer, which is considerably higher compared to the general population.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. FAMMM Syndrome:</strong> While FAMMM (familial atypical multiple mole melanoma) syndrome, associated with mutations in the p16/CDKN2A gene, increases the risk for melanoma and pancreatic cancer, its association with pancreatic cancer is not as strong as that seen in PJS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. FAP (Familial Adenomatous Polyposis):</strong> FAP, primarily known for its high risk of colorectal cancer, also has some association with other cancers including pancreatic cancer, but again not as high as PJS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hereditary pancreatitis:</strong> Typically caused by mutations in the PRSS1 gene, hereditary pancreatitis does increase the risk for pancreatic cancer, but the risk is less compared to PJS.</span></p><p><br><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Pancreatic cancer has highest association with Peutz Jeghers syndrome.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Hereditary risk factors -</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Peutz Jeghers syndrome- STK 11 (LKB1)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Hereditary pancreatitis – PRSS1 / SPIN 11</span></li><li><span style=\"color:black;font-size:12.0pt;\">Cystic fibrosis – CFTR</span></li><li><span style=\"color:black;font-size:12.0pt;\">FAMMM (familial atypical multiple mole melanoma)- p16/ CDKN2A</span></li><li><span style=\"color:black;font-size:12.0pt;\">Hereditary breast &amp;ovarian cancer- BRCA2</span></li><li><span style=\"color:black;font-size:12.0pt;\">HNPCC/ Lynch syndrome – MLH1, MSH2, MSH 6, PMS2</span></li></ul>",
      "correct_choice_id": 46565,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66669,
      "choices": [
        {
          "id": 265817,
          "text": "<p><span style=\"font-size:12.0pt;\">F18-Deoxyglucose</span></p>"
        },
        {
          "id": 265818,
          "text": "<p><span style=\"font-size:12.0pt;\">Tc99m</span></p>"
        },
        {
          "id": 265819,
          "text": "<p><span style=\"font-size:12.0pt;\">I131</span></p>"
        },
        {
          "id": 265820,
          "text": "<p><span style=\"font-size:12.0pt;\">Co60</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Radioactive isotope preferred in a patient with suspected metastatic thyroid cancer for whole body imaging: [Twisted PYQ]</span></p>",
      "unique_key": "Q4098887",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290248,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) I131</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">I131 (Iodine-131) is the preferred radioactive isotope for detecting thyroid cancer metastases because:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Thyroid tissue specifically takes up iodine</span></li><li><span style=\"font-size:12.0pt;\">It allows both imaging and treatment (theranostic agent)</span></li><li><span style=\"font-size:12.0pt;\">Long half-life suitable for whole-body imaging</span></li><li><span style=\"font-size:12.0pt;\">High sensitivity for detecting thyroid tissue and metastases</span></li><li><span style=\"font-size:12.0pt;\">Can be administered orally</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. F18-Deoxyglucose</strong>: While useful for many cancers, FDG-PET is less specific than I131 for thyroid cancer. It's mainly used for poorly differentiated thyroid cancers that don't concentrate iodine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Tc99m</strong>: While used in thyroid scans, it's mainly for routine thyroid imaging and not as effective for metastatic disease detection compared to I131.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Co60</strong>: Used in external beam radiotherapy for cancer treatment, not for diagnostic imaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">I131 is the gold standard for detecting well-differentiated thyroid cancer metastases</span></li><li><span style=\"font-size:12.0pt;\">Understanding the principle of theranostic agents (can be used for both therapy and diagnosis)</span></li><li><span style=\"font-size:12.0pt;\">Recognizing the importance of tissue-specific tracers in nuclear medicine</span></li><li><span style=\"font-size:12.0pt;\">Knowledge of different radioisotopes and their clinical applications</span></li></ol>",
      "correct_choice_id": 265819,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11753,
      "choices": [
        {
          "id": 46978,
          "text": "<p><span style=\"font-size:12.0pt;\">DC Cardioversion</span></p>"
        },
        {
          "id": 46979,
          "text": "<p><span style=\"font-size:12.0pt;\">Valsalva Maneuver</span></p>"
        },
        {
          "id": 46980,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine</span></p>"
        },
        {
          "id": 46981,
          "text": "<p><span style=\"font-size:12.0pt;\">Verapamil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient comes with palpitation to ER. His Pulse-180/min and BP-70mm of Hg systolic. ECG shows narrow QRS complex tachycardia with regular heart rate. What is the next step in management? (INICET NOV 2020)</span></p>",
      "unique_key": "Q9204954",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290249,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;DC cardioversion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a patient presenting with hemodynamically unstable symptoms such as a significantly low blood pressure and a high heart rate, as indicated by a pulse of 180/min and systolic BP of 70 mmHg, immediate DC cardioversion is indicated. This procedure is critical for restoring normal heart rhythm and preventing further cardiovascular compromise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Valsalva Maneuver: </strong>it&nbsp;is typically used in stable patients to attempt cardioversion of supraventricular tachycardia (SVT) back to a normal rhythm. It is not suitable for patients showing signs of hemodynamic instability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Adenosine: </strong>it&nbsp;is effective in terminating certain types of SVT by temporarily blocking the AV node but is used in stable patients. Given the patient's low BP, this is not the first-line approach.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Verapamil:&nbsp;</strong>it&nbsp;is a calcium channel blocker used for rate control in cases of SVT, more appropriate for stable patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">DC cardioversion is the emergency treatment of choice for a patient with hemodynamically unstable narrow QRS complex tachycardia, as it quickly restores normal rhythm and stabilizes the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21/Cardiology/SVT/chap 246</strong></span></p>",
      "correct_choice_id": 46978,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11249,
      "choices": [
        {
          "id": 44962,
          "text": "<p><span style=\"font-size:12.0pt;\">It is faster than AV nodal pathway</span></p>"
        },
        {
          "id": 44963,
          "text": "<p><span style=\"font-size:12.0pt;\">It is slower than AV nodal pathway</span></p>"
        },
        {
          "id": 44964,
          "text": "<p><span style=\"font-size:12.0pt;\">Leads to short PR interval</span></p>"
        },
        {
          "id": 44965,
          "text": "<p><span style=\"font-size:12.0pt;\">Leads to prolonged QRS duration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the false statement about the bundle of Kent? (NEET PG 2019)</span></p>",
      "unique_key": "Q9288286",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290250,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. It is slower than AV nodal pathway</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The false statement about the bundle of Kent is that it is slower than the AV nodal pathway. In fact, the bundle of Kent provides a rapid conduction pathway between the atrium and the ventricle, bypassing the AV node. This pathway allows for faster conduction than the AV nodal pathway due to the nature of the myocardial fibers involved and the lack of delay that normally occurs at the AV node.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. It is faster than the AV nodal pathway</strong>: This statement is actually true. The bundle of Kent facilitates faster electrical conduction from the atria to the ventricles by bypassing the slower AV node, contributing to the clinical manifestations of pre-excitation syndromes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Leads to a short PR interval</strong>: This is true. The rapid conduction via the bundle of Kent results in premature activation of the ventricles, reflected as a shortened PR interval on an electrocardiogram.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Leads to a prolonged QRS duration</strong>: This is also true. The activation of ventricular myocardium via the accessory pathway occurs in a less synchronized manner compared to normal conduction through the His-Purkinje system, leading to a broader and prolonged QRS complex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bundle of Kent is an accessory pathway connecting atrium and ventricle with conduction through Na+ channels leading to bypass of physiological AV conduction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Cardiology/WPW</strong></span></p>",
      "correct_choice_id": 44963,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11602,
      "choices": [
        {
          "id": 46374,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 46375,
          "text": "<p><span style=\"font-size:12.0pt;\">DC Cardioversion</span></p>"
        },
        {
          "id": 46376,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine</span></p>"
        },
        {
          "id": 46377,
          "text": "<p><span style=\"font-size:12.0pt;\">Verapamil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient presents to the hospital with palpitations. Her vitals are stable, and the ECG shows the following. Which of the following is used as first-line management to treat the condition?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/07/screenshot-2024-09-07-154211.png\" alt=\"\" width=\"300\" height=\"166\"></span></p>",
      "unique_key": "Q5065369",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290251,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Adenosine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's ECG shows a <strong>regular narrow complex tachycardia</strong>. This type of tachycardia, in a stable patient, is <strong>initially managed with vagal maneuvers such as carotid sinus massage or the Valsalva maneuver.</strong> These maneuvers aim to increase parasympathetic tone and slow conduction through the atrioventricular (AV) node. If vagal maneuvers are ineffective or not feasible, the next step is to administer an AV nodal blocker.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Adenosine is the first-line pharmacological treatment&nbsp;</strong>for stable, regular narrow complex tachycardia. It works by transiently blocking the AV node, thereby interrupting the re-entrant circuit responsible for the tachycardia. The initial dose of adenosine is <strong>6 mg</strong> administered rapidly IV push, followed by a 10 ml saline flush. If the tachycardia persists, additional doses of 12 mg may be given, with a <strong>maximum cumulative dose of 30 mg.</strong> Adenosine has a very short half-life of approximately 8 to 10 seconds, necessitating rapid (IV push) administration and immediate follow-up with normal saline to ensure efficacy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Amiodarone</strong>: Amiodarone is used for the treatment of various types of arrhythmias, including wide complex tachycardias (regular and monomorphic rhythm).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. DC Cardioversion</strong>: Direct current (DC) cardioversion is used in cases of hemodynamic instability or when pharmacological treatment fails. It is not the first-line treatment for a stable patient presenting with regular narrow complex tachycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Verapamil</strong>: Verapamil is a calcium channel blocker that can be used to manage atrial fibrillation (irregularly irregular rhythm, because in that case adenosine is contraindicated).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For stable, regular narrow complex tachycardia, adenosine is the first-line pharmacological treatment.</span></p>",
      "correct_choice_id": 46376,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16167,
      "choices": [
        {
          "id": 64628,
          "text": "<p><span style=\"font-size:12.0pt;\">Vancomycin</span></p>"
        },
        {
          "id": 64629,
          "text": "<p><span style=\"font-size:12.0pt;\">High dose fluconazole</span></p>"
        },
        {
          "id": 64630,
          "text": "<p><span style=\"font-size:12.0pt;\">Voriconazole</span></p>"
        },
        {
          "id": 64631,
          "text": "<p><span style=\"font-size:12.0pt;\">Liposomal amphotericin B with flucytosine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An HIV-positive man presents with a high-grade fever. Examination reveals a positive Kernig's sign. CSF shows reduced glucose, increased protein, and increased leukocytes. A diagnosis of cryptococcal meningitis is made. What is the appropriate management for this patient? (FMGE JAN 2023)</span></p>",
      "unique_key": "Q6305311",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290252,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) Liposomal amphotericin B with flucytosine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cryptococcal meningitis is a serious fungal infection that commonly affects immunocompromised patients, such as those with HIV. The standard first-line treatment for cryptococcal meningitis involves <strong>an induction therapy phase, typically with a combination of liposomal amphotericin B and flucytosine for at least 14 days.</strong> This regimen is effective in reducing the fungal burden and improving outcomes in these patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Vancomycin:</strong> This antibiotic is used primarily for bacterial infections, particularly those caused by Gram-positive bacteria. It is not effective against fungal infections such as cryptococcal meningitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. High dose fluconazole:</strong> While fluconazole is used in the treatment of cryptococcal meningitis, it is generally used after the initial induction phase with amphotericin B and flucytosine. High dose fluconazole can be part of the consolidation or maintenance therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Voriconazole:</strong> This antifungal is primarily used for infections caused by Aspergillus species and is not the preferred treatment for cryptococcal meningitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For cryptococcal meningitis in HIV-positive patients, the first-line induction therapy is a combination of liposomal amphotericin B and flucytosine for at least 14 days.</span></p>",
      "correct_choice_id": 64631,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11480,
      "choices": [
        {
          "id": 45886,
          "text": "<p><span style=\"font-size:12.0pt;\">Pantothenate kinase deficiency</span></p>"
        },
        {
          "id": 45887,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuroferritinopathy</span></p>"
        },
        {
          "id": 45888,
          "text": "<p><span style=\"font-size:12.0pt;\">Pelizaeus-Merzbacher disease</span></p>"
        },
        {
          "id": 45889,
          "text": "<p><span style=\"font-size:12.0pt;\">Aceruloplasminemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Tigroid white matter on MRI imaging is seen in which of the following conditions? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q4090903",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290253,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Pelizaeus-Merzbacher disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pelizaeus-Merzbacher disease (PMD) is a rare, genetic, demyelinating disorder of the central nervous system characterized by a distinctive \"tigroid\" pattern on MRI. This pattern arises from the preservation of perivascular myelin in the brain's white matter, interspersed with areas of demyelination, creating a striped or tigroid appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pantothenate kinase deficiency:&nbsp;</strong>This condition is also known as PKAN (Pantothenate Kinase-Associated Neurodegeneration). It typically shows a characteristic MRI feature known as the \"eye of the tiger\" sign, which involves a specific pattern of iron deposition in the basal ganglia. The \"eye of the tiger\" sign appears due to a combination of hyperintense signal surrounded by a region of hypointensity on T2-weighted MRI images, reflecting iron accumulation and gliosis. This is distinct from the tigroid pattern seen in demyelinating diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Neuroferritinopathy:&nbsp;</strong>Neuroferritinopathy is another disorder of iron metabolism that affects the brain, leading to iron accumulation, particularly in the basal ganglia. MRI findings in neuroferritinopathy typically do not include the tigroid pattern but may show abnormalities such as signal changes in the basal ganglia related to iron deposition. The imaging features here are more associated with iron accumulation rather than the patchy demyelination that produces the tigroid appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aceruloplasminemia:&nbsp;</strong>Aceruloplasminemia is a rare hereditary disorder characterized by iron accumulation in various tissues, including the brain. Similar to neuroferritinopathy, the primary MRI findings in aceruloplasminemia are related to iron deposition, particularly in the cerebellum and basal ganglia, and do not typically involve the tigroid pattern. Instead, the imaging might show evidence of iron accumulation without the specific changes associated with demyelination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pelizaeus-Merzbacher disease is a prototypical condition that displays a tigroid pattern on MRI. This appearance is due to the patchy preservation and destruction of myelin in the white matter, creating alternating areas of normal myelin and demyelination. This results in the characteristic striped or tigroid appearance on imaging studies, reflective of the disease’s impact on myelination.</span></p>",
      "correct_choice_id": 45888,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54292,
      "choices": [
        {
          "id": 216637,
          "text": "<p><span style=\"font-size:12.0pt;\">Osmotic diuretics → Collecting duct</span></p>"
        },
        {
          "id": 216638,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbonic Anhydrase inhibitors → Proximal convoluted tubule</span></p>"
        },
        {
          "id": 216639,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiazides → Loop of Henle</span></p>"
        },
        {
          "id": 216640,
          "text": "<p><span style=\"font-size:12.0pt;\">Aldosterone antagonists → Distal Convoluted tubule</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the correct match out of the following diuretics and the respective site of action:</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2925626",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290254,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>B) Carbonic Anhydrase inhibitors → Proximal convoluted tubule</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Carbonic Anhydrase inhibitors</strong>: These diuretics inhibit the enzyme carbonic anhydrase, which is located predominantly in the <strong>proximal convoluted tubule.</strong> This inhibition reduces the reabsorption of bicarbonate, sodium, and water in this segment, making \"Carbonic Anhydrase inhibitors → Proximal convoluted tubule\" the correct match.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Osmotic diuretics</strong>: These have a diffuse mechanism of action throughout the nephron, primarily affecting water-permeable regions such as the <strong>proximal convoluted tubule and the descending limb of the loop of Henle</strong>. The statement \"Osmotic diuretics → Collecting duct\" is incorrect as the major sites of action are the proximal convoluted tubule and the descending limb, not just the collecting duct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thiazides</strong>: Thiazide diuretics act on the <strong>distal convoluted tubule</strong> by inhibiting the sodium-chloride transporter. They do not primarily act on the Loop of Henle, making \"Thiazides → Loop of Henle\" incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aldosterone antagonists</strong>: These drugs act on the <strong>collecting ducts</strong>, particularly affecting the principal cells where aldosterone promotes sodium reabsorption and potassium secretion. Therefore, the statement \"Aldosterone antagonists → Distal Convoluted tubule\" is incorrect as their primary site of action is the collecting duct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Diuretics with their site of action:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Osmotic diuretics → Proximal convoluted tubule and the descending limb of the loop of Henle</span></li><li><span style=\"font-size:12.0pt;\">Carbonic Anhydrase inhibitors → Proximal convoluted tubule</span></li><li><span style=\"font-size:12.0pt;\">Thiazides → Distal convoluted tubule</span></li><li><span style=\"font-size:12.0pt;\">Aldosterone antagonists → Collecting duct</span></li></ul>",
      "correct_choice_id": 216638,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66672,
      "choices": [
        {
          "id": 265825,
          "text": "<p><span style=\"font-size:12.0pt;\">Kidney</span></p>"
        },
        {
          "id": 265826,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver</span></p>"
        },
        {
          "id": 265827,
          "text": "<p><span style=\"font-size:12.0pt;\">Intestine</span></p>"
        },
        {
          "id": 265828,
          "text": "<p><span style=\"font-size:12.0pt;\">Heart</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following transplants requires most extensive human leukocyte antigen (HLA) matching to prevent rejection? [Twisted PYQ]</span></p>",
      "unique_key": "Q7519329",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290255,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Kidney</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kidney transplantation requires the most extensive HLA matching among solid organ transplants because:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Kidney tissue is highly immunogenic</span></li><li><span style=\"font-size:12.0pt;\">Poor HLA matching significantly increases rejection risk</span></li><li><span style=\"font-size:12.0pt;\">Better HLA matching correlates with improved long-term graft survival</span></li><li><span style=\"font-size:12.0pt;\">Six antigen match (complete HLA match) shows best outcomes</span></li><li><span style=\"font-size:12.0pt;\">Highly sensitized patients benefit most from close HLA matching</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Liver</strong>: The liver is relatively tolerant to HLA mismatches and can be transplanted successfully with less stringent matching requirements.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Intestine</strong>: While immunologically active, intestinal transplants focus more on ABO compatibility than extensive HLA matching.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Heart</strong>: Heart transplants require ABO compatibility but are less dependent on extensive HLA matching compared to kidneys.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Understanding the importance of HLA matching in different organ transplants</span></li><li><span style=\"font-size:12.0pt;\">Recognition that kidney transplants are most sensitive to HLA mismatches</span></li><li><span style=\"font-size:12.0pt;\">Knowledge that different organs have varying immunological requirements</span></li><li><span style=\"font-size:12.0pt;\">Appreciation of factors affecting transplant success rates</span></li></ol>",
      "correct_choice_id": 265825,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11280,
      "choices": [
        {
          "id": 45086,
          "text": "<p><span style=\"font-size:12.0pt;\">Gliosis</span></p>"
        },
        {
          "id": 45087,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of myelin sheath</span></p>"
        },
        {
          "id": 45088,
          "text": "<p><span style=\"font-size:12.0pt;\">Defect at node of Ranvier</span></p>"
        },
        {
          "id": 45089,
          "text": "<p><span style=\"font-size:12.0pt;\">Leaky Na+ channel</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The slowing of conduction in multiple sclerosis is due to which of the following? (NEET PG 2020)</span></p>",
      "unique_key": "Q1654108",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290256,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Loss of myelin sheath</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Multiple sclerosis (MS) is primarily characterized by the autoimmune-mediated demyelination of central nervous system neurons. The myelin sheath is crucial for proper and fast electrical conduction along nerve fibers; it facilitates saltatory conduction, which allows the action potential to jump rapidly from one node of Ranvier to the next. The loss of this myelin sheath in MS results in significantly slowed and disrupted nerve signal conduction, which underlies many of the neurological symptoms associated with the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Gliosis:&nbsp;</strong>Gliosis is not seen in MS but seen in viral encephalitis, Alzheimer's disease, traumatic brain injury, and gliomas</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Defect at node of Ranvier:&nbsp;</strong>Although alterations in the nodes of Ranvier occur secondary to demyelination, the primary issue is the loss of the myelin sheath itself, not initial defects at the nodes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Leaky Na+ channel:&nbsp;</strong>This option refers to a specific type of channelopathy that isn't characteristic of MS. In MS, the problem is more about the insulation (myelin) around the nerve fibers rather than the ion channels within the nerve cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Multiple sclerosis is characterized by <strong>demyelination that results in loss of saltatory conduction occurring from one node of Ranvier to the other</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Multiple sclerosis/Chap 444</strong></span></p>",
      "correct_choice_id": 45087,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47639,
      "choices": [
        {
          "id": 190167,
          "text": "<p><span style=\"font-size:12.0pt;\">Microangiopathic anemia</span></p>"
        },
        {
          "id": 190168,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickling crisis</span></p>"
        },
        {
          "id": 190169,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia</span></p>"
        },
        {
          "id": 190170,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune hemolytic anemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with hemolytic anemia presents with index finger pain and chest pain. The patient has Hb of 5.6 gm/dl and an increase in unconjugated bilirubin in serum. What is the most likely diagnosis? (</span>FMGE Jan 2024)</p>",
      "unique_key": "Q9148844",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290257,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Sickling crisis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with hemolytic anemia, evidenced by a low hemoglobin level of 5.6 gm/dl and an increase in unconjugated bilirubin, indicating hemolysis. The specific symptoms of index finger pain and chest pain are highly suggestive of <strong>a sickling crisis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In sickle cell disease, patients may experience episodes of severe pain, known as sickle cell crises or vaso-occlusive crises, due to the blockage of blood flow by sickled red blood cells. The index finger pain (dactylitis) and chest pain (acute chest syndrome) are classic manifestations of such crises. Acute chest syndrome is a severe complication of sickle cell disease that presents with chest pain, fever, and pulmonary infiltrates.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Microangiopathic anemia</strong>: This condition involves the destruction of red blood cells in small blood vessels but does not typically present with the specific symptoms of dactylitis and acute chest syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thalassemia</strong>: While thalassemia also causes hemolytic anemia, it does not usually present with dactylitis or acute chest syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Autoimmune hemolytic anemia</strong>: This condition involves the immune system attacking red blood cells but lacks the specific signs of sickle cell crisis, such as dactylitis and acute chest syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with hemolytic anemia presenting with severe pain in the fingers (dactylitis) and chest pain (acute chest syndrome), sickle cell crisis is the most likely diagnosis.</span></p>",
      "correct_choice_id": 190168,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11450,
      "choices": [
        {
          "id": 45766,
          "text": "<p><span style=\"font-size:12.0pt;\">Clostridium</span></p>"
        },
        {
          "id": 45767,
          "text": "<p><span style=\"font-size:12.0pt;\">Klebsiella</span></p>"
        },
        {
          "id": 45768,
          "text": "<p><span style=\"font-size:12.0pt;\">Acinetobacter</span></p>"
        },
        {
          "id": 45769,
          "text": "<p><span style=\"font-size:12.0pt;\">Haemophilus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most likely causative organism of ventilator-associated pneumonia among the following? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q3282459",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290258,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Acinetobacter.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acinetobacter species are particularly prevalent in hospital settings and are a common cause of ventilator-associated pneumonia (VAP). These organisms are known for their ability to survive on surfaces for extended periods and their resistance to multiple antibiotics, making them a significant concern in intensive care units where patients are often intubated. Acinetobacter, along with Pseudomonas and Stenotrophomonas, is known for colonizing the respiratory tract of ventilated patients, leading to VAP, which typically occurs after 48 hours of mechanical ventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Clostridium:&nbsp;</strong>This genus, including species like Clostridium difficile, is more commonly associated with gastrointestinal infections, particularly antibiotic-associated diarrhea, rather than pneumonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Klebsiella:&nbsp;</strong>While Klebsiella pneumoniae can cause ventilator-associated pneumonia, it is generally less common than Acinetobacter in this specific infection context. Klebsiella tends to be more associated with community-acquired pneumonia and hospital-acquired infections outside of the ventilator context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Haemophilus:&nbsp;</strong>Haemophilus influenzae can cause respiratory tract infections but is more commonly linked to community-acquired pneumonia and exacerbations of chronic obstructive pulmonary disease rather than VAP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acinetobacter, pseudomonas, stenotrophomonas, Burkholderia cepacia are common organisms causing VAP. VAP occurs due to colonization by organisms in &lt; 48 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Pulmonology/Pneumonia/Chap 142</strong></span></p>",
      "correct_choice_id": 45768,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11814,
      "choices": [
        {
          "id": 47222,
          "text": "<p><span style=\"font-size:12.0pt;\">Natalizumab</span></p>"
        },
        {
          "id": 47223,
          "text": "<p><span style=\"font-size:12.0pt;\">Ocrelizumab</span></p>"
        },
        {
          "id": 47224,
          "text": "<p><span style=\"font-size:12.0pt;\">Fingolimod</span></p>"
        },
        {
          "id": 47225,
          "text": "<p><span style=\"font-size:12.0pt;\">Alemtuzumab</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following drugs is preferred in the management of primary progressive multiple sclerosis? (INICET NOV 2021)</span></p>",
      "unique_key": "Q5965774",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290259,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Ocrelizumab</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ocrelizumab is the preferred drug for the management of primary progressive multiple sclerosis (PPMS). PPMS is a form of multiple sclerosis characterized by a gradual progression of neurological symptoms without relapses. The reference paragraph highlights that Ocrelizumab is the only drug that has been shown to be effective in treating PPMS based on recent clinical trials. Ocrelizumab is a monoclonal antibody that targets CD20-positive B cells, which are believed to play a significant role in the pathogenesis of multiple sclerosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Natalizumab:</strong> This drug is used primarily for relapsing-remitting multiple sclerosis (RRMS). It works by inhibiting the migration of immune cells into the central nervous system, but it has not been shown to be effective in PPMS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Fingolimod:</strong> While Fingolimod is effective in treating RRMS, it is not the preferred treatment for PPMS. Fingolimod works by modulating sphingosine-1-phosphate receptors to prevent lymphocytes from reaching the central nervous system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Alemtuzumab:</strong> This drug is used for RRMS and works by depleting circulating T and B lymphocytes. It has not been demonstrated to be effective in treating PPMS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ocrelizumab is the only drug currently shown to be effective in the management of primary progressive multiple sclerosis (PPMS).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Remember</strong> - The drug that has been shown to be effective in treating secondary progressive multiple sclerosis (SPMS) is Siponimod, which is a sphingosine-1-phosphate receptor agonist.</span></p>",
      "correct_choice_id": 47223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20264,
      "choices": [
        {
          "id": 81017,
          "text": "<p><span style=\"font-size:12.0pt;\">Flunarizine</span></p>"
        },
        {
          "id": 81018,
          "text": "<p><span style=\"font-size:12.0pt;\">Sumatriptan</span></p>"
        },
        {
          "id": 81019,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 81020,
          "text": "<p><span style=\"font-size:12.0pt;\">Topiramate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient presents to you with a unilateral headache. It is associated with nausea, photophobia, and phonophobia. What is the best drug for acute management? (NEET PG 2023)</span></p>",
      "unique_key": "Q4176157",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290260,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. Sumatriptan</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms are characteristic of a migraine, which is often associated with unilateral headache, nausea, photophobia (sensitivity to light), and phonophobia (sensitivity to sound).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Sumatriptan:</strong> This medication is a serotonin receptor agonist (triptan) used for the acute treatment of migraine attacks. It works by stimulating serotonin (5-HT) receptors in the brain, leading to vasoconstriction of dilated blood vessels and relief from migraine symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The best drug for acute management of a migraine attack in this scenario is Sumatriptan.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Flunarizine:</strong> This is a calcium channel blocker used for the prophylactic treatment of migraine, not for acute management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Propranolol:</strong> This beta-blocker is also used for migraine prophylaxis, not for acute attacks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Topiramate:</strong> Used for preventing migraine, not for treating an acute attack.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educaitonal Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sumatriptan is the best medication for the acute management of migraine, characterized by unilateral headache, nausea, photophobia, and phonophobia.</span></p>",
      "correct_choice_id": 81018,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11703,
      "choices": [
        {
          "id": 46778,
          "text": "<p><span style=\"font-size:12.0pt;\">Total blood count with peripheral smear</span></p>"
        },
        {
          "id": 46779,
          "text": "<p><span style=\"font-size:12.0pt;\">CT thorax</span></p>"
        },
        {
          "id": 46780,
          "text": "<p><span style=\"font-size:12.0pt;\">Start cyclophosphamide</span></p>"
        },
        {
          "id": 46781,
          "text": "<p><span style=\"font-size:12.0pt;\">Urgent referral to RT</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 53-year-old patient was admitted complains of dyspnea. On examination he has puffy face, with engorged veins over the chest. SVC obstruction is suspected. Chest X-ray shows mediastinal enlargement. What is the next step? (AIIMS NOV 2018)</span></p>",
      "unique_key": "Q7216020",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290261,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) CT thorax</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Superior Vena Cava (SVC) obstruction, suggested by symptoms like dyspnea, facial puffiness, and engorged chest veins, along with a chest X-ray showing mediastinal enlargement, requires further detailed imaging to accurately assess the extent of the obstruction and the presence of any mediastinal masses. A CT scan of the thorax is the most appropriate next step as it provides detailed images of the chest's anatomy, helping to identify the cause of the SVC obstruction, which is crucial for planning appropriate management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Total blood count with peripheral smear:&nbsp;</strong>While useful for general health assessments and diagnosing blood disorders, this does not directly address the structural issues seen in SVC obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Start cyclophosphamide:&nbsp;</strong>Beginning chemotherapy like cyclophosphamide would only be appropriate after a specific diagnosis of a malignancy causing the SVC obstruction, confirmed via imaging and biopsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urgent referral to RT:&nbsp;</strong>Referral for radiation therapy (RT) may be necessary if a malignancy is confirmed, but it is premature without a detailed thoracic CT and biopsy if indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CT thorax is critical for detailed evaluation in suspected SVC obstruction to confirm the diagnosis and guide further specific treatment, whether surgical, medical, or radiation therapy.</span></p>",
      "correct_choice_id": 46779,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55401,
      "choices": [
        {
          "id": 221065,
          "text": "<p><span style=\"font-size:12pt;\">CN III</span></p>"
        },
        {
          "id": 221066,
          "text": "<p><span style=\"font-size:12pt;\">CN IV</span></p>"
        },
        {
          "id": 221067,
          "text": "<p><span style=\"font-size:12pt;\">CN VI</span></p>"
        },
        {
          "id": 221068,
          "text": "<p><span style=\"font-size:12pt;\">CN VII</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Innervation of lateral rectus is by which nerve? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q5673004",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290262,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) CN VI</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The lateral rectus muscle, which is responsible for moving the eye laterally (abduction), is innervated by the sixth cranial nerve, also known as the abducens nerve. This nerve specifically controls the lateral rectus muscle, allowing for the lateral movement of the eyeball.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. CN III (Oculomotor nerve):</strong> The oculomotor nerve innervates most of the other extraocular muscles, including the medial rectus, superior rectus, inferior rectus, and inferior oblique muscles. It is not responsible for innervating the lateral rectus muscle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. CN IV (Trochlear nerve):</strong> The trochlear nerve innervates only the superior oblique muscle, which is involved in downward and outward movement of the eye. It does not innervate the lateral rectus muscle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. CN VII (Facial nerve):</strong> The facial nerve is primarily responsible for the muscles of facial expression. It does not innervate any of the extraocular muscles, including the lateral rectus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The lateral rectus muscle is innervated by the sixth cranial nerve (CN VI), also known as the abducens nerve.</span></p>",
      "correct_choice_id": 221067,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11363,
      "choices": [
        {
          "id": 45418,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypokalemia</span></p>"
        },
        {
          "id": 45419,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperkalemia</span></p>"
        },
        {
          "id": 45420,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypomagnesemia</span></p>"
        },
        {
          "id": 45421,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypernatremia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A man on diuretics presents with weakness. An ECG was done which showed flat T waves and prominent U waves. What is the most likely diagnosis? (Neet pg 2022)</span></p>",
      "unique_key": "Q8614162",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290263,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A. Hypokalemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypokalemia is a condition characterized by low potassium levels in the blood, which can occur in patients taking diuretics. Diuretics increase the excretion of potassium in the urine, leading to its depletion. The <strong>triad of ECG changes&nbsp;</strong>associated with hypokalemia are distinctive and include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Flattening of T waves</strong>: This is often the earliest change observed in hypokalemia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Prominent U waves</strong>: These waves become more visible as the potassium levels drop further.</span></li><li><span style=\"font-size:12.0pt;\"><strong>ST depression</strong>: This can occur in more severe cases of hypokalemia.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These ECG changes are due to the altered repolarization of the heart muscle cells caused by low potassium levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B.</strong> <strong>Hyperkalemia</strong>: Hyperkalemia, or high potassium levels, typically presents with different ECG changes, such as <strong>tall, peaked T waves, wide QRS complexes, and possibly absent P waves.</strong> These findings are not consistent with the patient's ECG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C.</strong> <strong>Hypomagnesemia</strong>: While low magnesium can cause ECG changes and muscle weakness, the specific ECG findings in this case (flat T waves and prominent U waves) are more indicative of hypokalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D.</strong> <strong>Hypernatremia</strong>: High sodium levels do not typically cause specific ECG changes. Severe hypernatremia might cause cerebral edema and nonspecific T wave inversions, but it does not lead to the characteristic ECG findings seen with hypokalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypokalemia is characterized by ECG changes such as flattened T waves, prominent U waves, and ST depression. It is commonly seen in patients on diuretics, and recognizing these ECG patterns is crucial for diagnosis and management.</span></p>",
      "correct_choice_id": 45418,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50959,
      "choices": [
        {
          "id": 203377,
          "text": "<p><span style=\"font-size:12.0pt;\">i, ii, iii, iv</span></p>"
        },
        {
          "id": 203378,
          "text": "<p><span style=\"font-size:12.0pt;\">i, ii, iii, vi&nbsp;</span></p>"
        },
        {
          "id": 203379,
          "text": "<p><span style=\"font-size:12.0pt;\">i, ii, iii, v&nbsp;</span></p>"
        },
        {
          "id": 203380,
          "text": "<p><span style=\"font-size:12.0pt;\">i, ii, iv, v&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old male presents with increased thirst and increased frequency and volume of urination. He has no other symptoms. His random blood sugar was 205 mg/dl, what appropriate investigations should be done? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023)</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12.0pt;\">HbA1c</span></li><li><span style=\"font-size:12.0pt;\">Urine ACR</span></li><li><span style=\"font-size:12.0pt;\">Echocardiography</span></li><li><span style=\"font-size:12.0pt;\">Fundoscopy</span></li><li><span style=\"font-size:12.0pt;\">ECG</span></li><li><span style=\"font-size:12.0pt;\">Serum protein electrophoresis</span></li></ol>",
      "unique_key": "Q1824468",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290264,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D)&nbsp;i, ii, iv, v</strong></span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">The patient presents with hyperglycemia (random blood sugar of 205 mg/dl), indicating diabetes. The appropriate investigations for a newly diagnosed diabetic patient are:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. HbA1c:&nbsp;</strong>To assess long-term glycemic control and confirm the diagnosis of diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Urine ACR (Albumin-to-Creatinine Ratio):&nbsp;</strong>To screen for diabetic nephropathy, as microalbuminuria is an early sign of kidney damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Fundoscopy:&nbsp;</strong>To check for diabetic retinopathy and other microvascular changes in the eyes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>5. ECG:&nbsp;</strong>To screen for any cardiovascular complications, as diabetes increases the risk of heart disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Echocardiography</strong>: Not a routine screening test for diabetes unless there is a specific indication, such as suspected heart failure or structural heart disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>6. Serum protein electrophoresis: </strong>Not indicated in the routine evaluation of diabetes and is used to diagnose conditions like multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a newly diagnosed diabetic patient, essential investigations include HbA1c, urine ACR, fundoscopy, and ECG to assess glycemic control, kidney function, eye health, and cardiovascular risk, respectively.</span></p>",
      "correct_choice_id": 203380,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11512,
      "choices": [
        {
          "id": 46014,
          "text": "<p><span style=\"font-size:12.0pt;\">Age &lt; 60 years</span></p>"
        },
        {
          "id": 46015,
          "text": "<p><span style=\"font-size:12.0pt;\">Duration of TIA &gt; 5 mins</span></p>"
        },
        {
          "id": 46016,
          "text": "<p><span style=\"font-size:12.0pt;\">SBP &gt; 140 mm Hg and DBP &lt; 90 mmHg</span></p>"
        },
        {
          "id": 46017,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">All of the factors would suggest a higher risk for a patient with TIA developing stroke in the future according to ABCD2 scoring except? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q2620664",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290265,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Age &lt; 60 years</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ABCD2 score is a clinical tool used to predict the short-term risk of stroke after a transient ischemic attack (TIA). The scoring system includes several factors that help assess this risk. Here’s why option A is the correct answer:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Age &lt; 60 years:&nbsp;</strong>According to the ABCD2 scoring system, a patient who is aged 60 years or older scores 1 point, indicating a higher risk. Therefore, being younger than 60 does not contribute to an increased score, making it the correct choice for the exception in this question.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Duration of TIA &gt; 5 mins:&nbsp;</strong>In the ABCD2 score, the duration of the TIA is an important factor. TIA lasting 10-59 minutes scores 1 point, and TIA lasting more than 60 minutes scores 2 points. Duration less than 10 minutes would score 0. However, since the option simply says \"Duration of TIA &gt; 5 mins,\" without specifying how much longer, it's less clearly defined in this question, but generally longer durations imply a higher score.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. SBP &gt; 140 mm Hg and DBP &lt; 90 mmHg:&nbsp;</strong>High blood pressure at the time of TIA, defined as SBP ≥ 140 mm Hg or DBP ≥ 90 mm Hg, scores 1 point in the ABCD2 score.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Diabetes:&nbsp;</strong>The presence of diabetes in a patient who has experienced a TIA adds 1 point to the ABCD2 score.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture39.jpg\" alt=\"\" width=\"1000\" height=\"365\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Additional D3-Dual TIA (within 7 days of first TIA), Imaging (MRI, DWI) were added to original score. However, all these perform very poorly in the light of recent evidences.</span></p>",
      "correct_choice_id": 46014,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11533,
      "choices": [
        {
          "id": 46098,
          "text": "<p><span style=\"font-size:12.0pt;\">Fixed distal airway obstruction</span></p>"
        },
        {
          "id": 46099,
          "text": "<p><span style=\"font-size:12.0pt;\">Fixed central airway obstruction</span></p>"
        },
        {
          "id": 46100,
          "text": "<p><span style=\"font-size:12.0pt;\">Variable intrathoracic obstruction</span></p>"
        },
        {
          "id": 46101,
          "text": "<p><span style=\"font-size:12.0pt;\">Variable extra thoracic obstruction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the pathology from the given flow-volume loop: (INICET MAY 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-154508.png\" alt=\"\" width=\"300\" height=\"259\"></span></p>",
      "unique_key": "Q7690013",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290266,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B) Fixed central airway obstruction</strong></span></p><p><br><span style=\"font-size:12pt;\">The flow-volume loop shows flattening of both the inspiratory and expiratory limbs, which is characteristic of a fixed central airway obstruction. This pattern suggests an obstruction that affects airflow both during inhalation and exhalation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Fixed distal airway obstruction</strong> would not typically affect both phases of the loop.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Variable intrathoracic obstruction</strong> affects the expiratory phase more.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Variable extrathoracic obstruction</strong> affects the inspiratory phase more.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Flattening of both inspiratory and expiratory limbs in a flow-volume loop indicates a fixed central airway obstruction.</span></p>",
      "correct_choice_id": 46099,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 52310,
      "choices": [
        {
          "id": 208737,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyoscine</span></p>"
        },
        {
          "id": 208738,
          "text": "<p><span style=\"font-size:12.0pt;\">Benzhexol</span></p>"
        },
        {
          "id": 208739,
          "text": "<p><span style=\"font-size:12.0pt;\">Levodopa</span></p>"
        },
        {
          "id": 208740,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyproheptadine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient was treated with repeated doses of IV anti-emetic for severe vomiting. The patient now does not have vomiting but developed abnormal movements. What is the most appropriate treatment?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2021)</span></p>",
      "unique_key": "Q2521106",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290267,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Benzhexol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient likely received intravenous metoclopramide, a common anti-emetic, which can cause extrapyramidal side effects such as dystonia. Dystonia is a movement disorder characterized by involuntary muscle contractions, leading to repetitive movements or abnormal postures. This condition can be painful and distressing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The treatment of choice for drug-induced dystonia is an anticholinergic medication. Benzhexol (also known as trihexyphenidyl) is an anticholinergic drug that can effectively relieve dystonic reactions by blocking acetylcholine receptors in the central nervous system, thereby restoring the balance between dopamine and acetylcholine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hyoscine:</strong> Hyoscine (scopolamine) is primarily used to treat motion sickness and postoperative nausea. It is not effective for treating dystonia induced by anti-emetic medications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Levodopa:</strong> Levodopa is used to treat Parkinson's disease by increasing dopamine levels in the brain. It is not appropriate for treating acute dystonic reactions caused by anti-emetic medications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cyproheptadine:</strong> Cyproheptadine is an antihistamine with antiserotonergic and anticholinergic properties. While it can be used for some dystonic reactions, it is not the first-line treatment in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For patients who develop dystonic reactions after receiving anti-emetic medications like metoclopramide, the most appropriate treatment is an anticholinergic drug such as benzhexol (trihexyphenidyl). This helps alleviate the abnormal movements by restoring the balance between dopamine and acetylcholine in the central nervous system.</span></p>",
      "correct_choice_id": 208738,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20271,
      "choices": [
        {
          "id": 81045,
          "text": "<p><span style=\"font-size:12.0pt;\">DDAVP for 2 weeks and then discontinue</span></p>"
        },
        {
          "id": 81046,
          "text": "<p><span style=\"font-size:12.0pt;\">DDAVP supplementation for lifelong</span></p>"
        },
        {
          "id": 81047,
          "text": "<p><span style=\"font-size:12.0pt;\">Upsetting of receptors so no treatment is required</span></p>"
        },
        {
          "id": 81048,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiazides for 2 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient came to the medical OPD with complaints of polyuria. He has a history of undergoing total hypophysectomy. His Na<sup>+</sup> levels are found to be 155 mEq/L, urine osmolality was 200 mOsm/L. What is the definitive management? (NEET PG 2023)</span></p>",
      "unique_key": "Q6225083",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290268,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. DDAVP supplementation for lifelong</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's presentation of polyuria and low urine osmolality (200 mOsm/L) with hypernatremia (Na+ 155 mEq/L) is indicative of diabetes insipidus (DI). Given the history of total hypophysectomy, this is most likely central diabetes insipidus (CDI), where the pituitary gland no longer produces antidiuretic hormone (ADH, also known as vasopressin).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In CDI, the definitive treatment is <strong>desmopressin (DDAVP</strong>), a synthetic analog of ADH. Desmopressin helps to reduce urine output and correct hypernatremia by promoting water reabsorption in the kidneys. Since the condition is permanent due to the hypophysectomy, lifelong supplementation with desmopressin is necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. DDAVP for 2 weeks and then discontinue:</strong> Discontinuing DDAVP after 2 weeks is not appropriate as the patient will continue to suffer from polyuria and hypernatremia due to the lack of ADH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Upsetting of receptors so no treatment is required</strong>: This option is incorrect as the patient's symptoms and lab findings clearly indicate the need for treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Thiazides for 2 weeks:</strong> Thiazides are used in nephrogenic diabetes insipidus (NDI) to reduce urine output by increasing ADH sensitivity. However, in central diabetes insipidus, thiazides are not effective because the issue is the absence of ADH, not a problem with the kidneys' response to it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with central diabetes insipidus following total hypophysectomy, lifelong desmopressin (DDAVP) supplementation is required to manage symptoms and prevent complications from persistent polyuria and hypernatremia.</span></p>",
      "correct_choice_id": 81046,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66674,
      "choices": [
        {
          "id": 265833,
          "text": "<p><span style=\"font-size:12.0pt;\">Cholangitis</span></p>"
        },
        {
          "id": 265834,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic Perforation</span></p>"
        },
        {
          "id": 265835,
          "text": "<p><span style=\"font-size:12.0pt;\">Bleeding</span></p>"
        },
        {
          "id": 265836,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancreatitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Most common complication following percutaneous transhepatic cholangiography (PTC) is? [Twisted PYQ]</span></p>",
      "unique_key": "Q5398205",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290269,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Bleeding</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bleeding is the most common complication of PTC, occurring in approximately 2-12% of cases. This is because:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The procedure involves needle puncture through liver tissue</span></li><li><span style=\"font-size:12.0pt;\">The liver is highly vascular</span></li><li><span style=\"font-size:12.0pt;\">Coagulopathy is common in patients with biliary disease</span></li><li><span style=\"font-size:12.0pt;\">Multiple passes may be needed to access the biliary system</span></li><li><span style=\"font-size:12.0pt;\">Both arterial and venous bleeding can occur</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cholangitis</strong>: While significant, it occurs less frequently than bleeding and is usually preventable with prophylactic antibiotics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hepatic Perforation</strong>: A rare complication that usually occurs during track dilation rather than initial access.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pancreatitis</strong>: Unlike ERCP, PTC rarely affects the pancreas as it approaches the biliary system from above, making pancreatitis an uncommon complication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Understanding the common complications of PTC</span></li><li><span style=\"font-size:12.0pt;\">Recognition that bleeding risk is inherent due to liver vascularity</span></li><li><span style=\"font-size:12.0pt;\">Appreciating the anatomical basis of complications</span></li><li><span style=\"font-size:12.0pt;\">Knowledge of preventive measures and risk assessment before the procedure</span></li></ol>",
      "correct_choice_id": 265835,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11210,
      "choices": [
        {
          "id": 44806,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased myosin</span></p>"
        },
        {
          "id": 44807,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased acetylcholine release at the nerve endings</span></p>"
        },
        {
          "id": 44808,
          "text": "<p><span style=\"font-size:12.0pt;\">Absence of troponin C</span></p>"
        },
        {
          "id": 44809,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased synaptic transmission at the myoneural junction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Myasthenia gravis is associated with: (NEET PG 2018)</span></p>",
      "unique_key": "Q9451330",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290270,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Decreased synaptic transmission at the myoneural junction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Myasthenia gravis is an autoimmune disorder where antibodies target and destroy acetylcholine receptors at the neuromuscular junction. This impairs the ability of the neurotransmitter acetylcholine to stimulate muscle contractions, leading to decreased synaptic transmission. The disease is characterized by muscle weakness and fatigue, particularly worsening with activity and improving with rest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Decreased myosin:&nbsp;</strong>This option is not related to myasthenia gravis, which primarily affects the neurotransmitter receptors, not the muscle fiber proteins like myosin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Decreased acetylcholine release at the nerve endings:&nbsp;</strong>While decreased acetylcholine release can affect neuromuscular function, in myasthenia gravis, the principal issue is the reduced effectiveness of acetylcholine at the neuromuscular junction due to antibody-mediated receptor damage, not a reduction in its release. Occurs with <strong>pre-synaptic blockers like bungarotoxin of krait</strong> causing reduced release of Ach rendering neostigmine ineffective.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Absence of troponin C:&nbsp;</strong>This is unrelated to the pathophysiology of myasthenia gravis. Troponin C is involved in the regulation of muscle contraction in skeletal and cardiac muscle, not neurotransmitter release or receptor function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Myasthenia Gravis is an autoimmune disease characterized by <strong>Ab to postsynaptic acetylcholine receptors</strong>. Hence, treated with steroids and immunomodulators.</span></p>",
      "correct_choice_id": 44809,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47518,
      "choices": [
        {
          "id": 189683,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood pressure control</span></p>"
        },
        {
          "id": 189684,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate thrombolysis</span></p>"
        },
        {
          "id": 189685,
          "text": "<p><span style=\"font-size:12.0pt;\">Clotting factor administration</span></p>"
        },
        {
          "id": 189686,
          "text": "<p><span style=\"font-size:12.0pt;\">Edema management</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old patient presented with acute onset left-sided hemiparesis. The symptoms started 3 hours ago. On examination, BP is 200/100 mm Hg. CT head is shown below. Which of the following should not be done in this patient?&nbsp;</span>(FMGE JULY 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-145400.png\" alt=\"\" width=\"300\" height=\"378\"></span></p>",
      "unique_key": "Q2212825",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290271,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Immediate thrombolysis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient has presented with acute onset left-sided hemiparesis, and the CT scan shows evidence of intracerebral hemorrhage (ICH), indicating a hemorrhagic stroke. In the case of hemorrhagic stroke, immediate thrombolysis is contraindicated as it can worsen the bleeding. Thrombolytic agents, such as tissue plasminogen activator (tPA), are used to dissolve clots in ischemic strokes but can be harmful in hemorrhagic strokes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Blood pressure control:&nbsp;</strong>Managing high blood pressure is crucial in patients with hemorrhagic stroke to prevent further bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Clotting factor administration:&nbsp;</strong>In cases of hemorrhagic stroke, administering clotting factors or other agents to help control bleeding may be necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Edema management:&nbsp;</strong>Managing cerebral edema is essential to reduce intracranial pressure and prevent further complications in hemorrhagic stroke patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Immediate thrombolysis should never be administered in patients with hemorrhagic stroke, as it can exacerbate the bleeding and worsen the patient's condition.</span></p>",
      "correct_choice_id": 189684,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24779,
      "choices": [
        {
          "id": 99077,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2</span></p>"
        },
        {
          "id": 99078,
          "text": "<p><span style=\"font-size:12.0pt;\">3,4</span></p>"
        },
        {
          "id": 99079,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2,3,4,5</span></p>"
        },
        {
          "id": 99080,
          "text": "<p><span style=\"font-size:12.0pt;\">2,3,4,5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are true about subclinical myocarditis? (INICET MAY 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Palpitations</span></li><li><span style=\"font-size:12.0pt;\">Elevated BNP Troponins</span></li><li><span style=\"font-size:12.0pt;\">Regional wall motion abnormalities in echo</span></li><li><span style=\"font-size:12.0pt;\">ECG suggestive of myocarditis</span></li><li><span style=\"font-size:12.0pt;\">Low LVEF in echo</span></li></ol>",
      "unique_key": "Q9009228",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290272,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 2,3,4,5</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Subclinical myocarditis may not present with symptoms like palpitations, but can show:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2. Elevated BNP/Troponins: Indicating myocardial injury.</span></p><p><span style=\"font-size:12.0pt;\">3. Regional wall motion abnormalities: Seen on echocardiography.</span></p><p><span style=\"font-size:12.0pt;\">4. ECG changes: Suggestive of myocarditis, such as non-specific ST-T changes.</span></p><p><span style=\"font-size:12.0pt;\">5. Low LVEF: Indicative of impaired left ventricular function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Palpitations are not a feature of subclinical myocarditis.</span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Subclinical myocarditis can present with elevated cardiac biomarkers, regional wall motion abnormalities, ECG changes, and reduced LVEF, but not Palpitations, which is common in viral myocarditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Past common causes of myocarditis: Coxsackie virus types A and B.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Currently, Most common cause of myocarditis: Parvovirus B19 and HHV6.</span></p>",
      "correct_choice_id": 99080,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11253,
      "choices": [
        {
          "id": 44978,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal ECG</span></p>"
        },
        {
          "id": 44979,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular fibrillation</span></p>"
        },
        {
          "id": 44980,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular tachycardia</span></p>"
        },
        {
          "id": 44981,
          "text": "<p><span style=\"font-size:12.0pt;\">Misplaced leads</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the diagnosis of this patient from the ECG shown below? (NEET PG 2019)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/23/screenshot-2024-07-23-130813.jpg\" alt=\"\" width=\"500\" height=\"285\"></p>",
      "unique_key": "Q1041955",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290273,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Ventricular tachycardia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ECG displays a rhythm with broad QRS complexes at a high rate, consistent with ventricular tachycardia (VT). VT is characterized by three or more consecutive ventricular beats at a rate of more than 100 beats per minute. The presence of such a pattern, particularly with a stable, repetitive form as seen in the ECG, strongly points to VT rather than other types of arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Normal ECG:&nbsp;</strong>This option is incorrect as the ECG clearly shows an abnormal rhythm with broad QRS complexes, indicative of an arrhythmia originating below the AV node.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ventricular fibrillation:&nbsp;</strong>Ventricular fibrillation is characterized by irregular, chaotic electrical activity without identifiable QRS complexes, P waves, or T waves. The rhythm shown here is too organized and regular to be VF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Misplaced leads:</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12pt;\">Misplaced leads causes <strong>positive p in aVR</strong> <strong>with normal intervals</strong> - R wave progression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ventricular tachycardia is identified by regular, broad QRS complexes at a rapid rate, distinct from the irregular pattern of ventricular fibrillation and the organized, narrower complexes typically seen with supraventricular rhythms and correct lead placement. Identifying VT on an ECG is critical due to its potential severity and the need for prompt treatment.</span></p>",
      "correct_choice_id": 44980,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11610,
      "choices": [
        {
          "id": 46406,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4, 3</span></p>"
        },
        {
          "id": 46407,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4, 3, 2</span></p>"
        },
        {
          "id": 46408,
          "text": "<p><span style=\"font-size:12.0pt;\">4, 3, 2, 1</span></p>"
        },
        {
          "id": 46409,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4, 3, 1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with fever and nuchal rigidity. The resident was instructed to perform a lumbar puncture on this patient. What is the correct order of managing this patient?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Place IV cannula and give fluids at 40 mL/h</span></li><li><span style=\"font-size:12.0pt;\">Start injection ceftriaxone</span></li><li><span style=\"font-size:12.0pt;\">Send CSF sample for biochemistry and microanalysis</span></li><li><span style=\"font-size:12.0pt;\">Perform guarded lumbar puncture</span></li></ol>",
      "unique_key": "Q7016773",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290274,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1, 4, 3, 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When managing a patient with fever and nuchal rigidity (suggesting possible meningitis), the correct order of steps is:</span></p><ol><li><span style=\"font-size:12.0pt;\">Place IV cannula and give fluids at 40 mL/h: Establishing IV access is the first priority to ensure hydration and create a route for medication administration.</span></li><li><span style=\"font-size:12.0pt;\">4. Perform guarded lumbar puncture: The lumbar puncture should be performed early to collect CSF samples before antimicrobial therapy alters the CSF findings.</span></li><li><span style=\"font-size:12.0pt;\">Send CSF sample for biochemistry and microanalysis: Once the CSF is collected, it must be promptly sent for laboratory analysis to identify potential pathogens and guide targeted therapy.</span></li><li><span style=\"font-size:12.0pt;\">Start injection ceftriaxone: After CSF collection, empiric antibiotic therapy with ceftriaxone should be initiated. This ensures that treatment doesn't interfere with CSF culture results while still providing timely antimicrobial coverage.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This sequence prioritizes obtaining diagnostic samples before starting antimicrobial therapy, which is critical for accurate diagnosis while not unduly delaying treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In suspected meningitis, the ideal sequence is to secure samples for microbiological diagnosis before starting antibiotics, when clinically feasible. However, if there will be a significant delay in performing the lumbar puncture or if the patient is critically ill, antibiotics should not be delayed. The sequence emphasizes balancing the need for accurate diagnosis with timely intervention.</span></p>",
      "correct_choice_id": 46407,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16168,
      "choices": [
        {
          "id": 64632,
          "text": "<p><span style=\"font-size:12.0pt;\">Lanreotide depot formulation</span></p>"
        },
        {
          "id": 64633,
          "text": "<p><span style=\"font-size:12.0pt;\">Terlipressin</span></p>"
        },
        {
          "id": 64634,
          "text": "<p><span style=\"font-size:12.0pt;\">Ketoconazole</span></p>"
        },
        {
          "id": 64635,
          "text": "<p><span style=\"font-size:12.0pt;\">Leuprolide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 29-year-old male patient presents to the OPD with a 10-year history of coarse facial features and progressive enlargement of the hands and feet. Laboratory evaluation revealed elevated IGF-1 and non-suppressible growth hormone levels after the 75 g glucose challenge test. A diagnosis of acromegaly is made. Which of the following drugs is preferred for the management of this condition? (FMGE JAN 2023)</span></p>",
      "unique_key": "Q6619010",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290275,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) Lanreotide depot formulation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acromegaly is a condition caused by excess growth hormone, often due to a growth hormone-secreting pituitary adenoma. The clinical features include coarse facial features and enlargement of the hands and feet. The diagnosis is confirmed with <strong>elevated IGF-1 levels</strong> <strong>and non-suppressible growth hormone levels </strong>following a glucose challenge test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The first-line treatment&nbsp;</strong>for a growth hormone-secreting pituitary adenoma is <strong>transsphenoidal surgery</strong>. However, when surgery is not immediately possible or has failed, medical management is necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The preferred drugs in these situations are <strong>somatostatin receptor agonists</strong>, such as <strong>lanreotide, octreotide, and pasireotide</strong>. Lanreotide depot formulation is effective in reducing growth hormone levels and controlling symptoms of acromegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Terlipressin:</strong> Incorrect. Terlipressin is primarily used in the management of <strong>acute variceal bleeding</strong> related to liver conditions, not in the treatment of acromegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Ketoconazole:</strong> Incorrect. Ketoconazole is used in managing <strong>Cushing's syndrome</strong> in children due to its ability to inhibit cortisol synthesis. It is not indicated for the treatment of acromegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Leuprolide:</strong> Incorrect. Leuprolide is a GnRH analogue used in the management <strong>of gynecological conditions such as fibroids and in prostate cancer</strong>. It is not effective in treating acromegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The preferred medical management for acromegaly, especially as a bridge to surgery or when surgery has failed, is the use of somatostatin receptor agonists like lanreotide depot formulation.</span></p>",
      "correct_choice_id": 64632,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66676,
      "choices": [
        {
          "id": 265841,
          "text": "<p><span style=\"font-size:12.0pt;\">Coiling</span></p>"
        },
        {
          "id": 265842,
          "text": "<p><span style=\"font-size:12.0pt;\">Mechanical thrombectomy</span></p>"
        },
        {
          "id": 265843,
          "text": "<p><span style=\"font-size:12.0pt;\">Basal stent placement</span></p>"
        },
        {
          "id": 265844,
          "text": "<p><span style=\"font-size:12.0pt;\">Balloon Angioplasty</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Interventional technique most commonly used for the management of acute ischemic stroke within the therapeutic window: [Twisted PYQ]</span></p>",
      "unique_key": "Q7282339",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290276,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Mechanical thrombectomy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mechanical thrombectomy is the primary endovascular intervention for acute ischemic stroke because:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">It directly removes the occluding thrombus</span></li><li><span style=\"font-size:12.0pt;\">Has a therapeutic window up to 6-24 hours in selected patients</span></li><li><span style=\"font-size:12.0pt;\">Can be used with or without IV thrombolysis</span></li><li><span style=\"font-size:12.0pt;\">Shows high recanalization rates</span></li><li><span style=\"font-size:12.0pt;\">Improves functional outcomes in large vessel occlusions</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Coiling</strong>: Used for treating aneurysms, not for acute stroke. It occludes vessels rather than opening them.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Basal stent placement</strong>: While stents may be used in chronic stenosis, they're not the primary treatment for acute stroke where immediate recanalization is needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Balloon Angioplasty</strong>: Though sometimes used in stroke treatment, it's usually adjunctive to thrombectomy and carries a risk of vessel damage or distal embolization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Understanding the role of mechanical thrombectomy in acute stroke</span></li><li><span style=\"font-size:12.0pt;\">Knowledge of therapeutic time windows for intervention</span></li><li><span style=\"font-size:12.0pt;\">Recognition of appropriate interventional techniques for different cerebrovascular conditions</span></li><li><span style=\"font-size:12.0pt;\">Appreciation of evidence-based approaches to acute stroke management</span></li></ol>",
      "correct_choice_id": 265842,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11481,
      "choices": [
        {
          "id": 45890,
          "text": "<p><span style=\"font-size:12.0pt;\">RA factor</span></p>"
        },
        {
          "id": 45891,
          "text": "<p><span style=\"font-size:12.0pt;\">Cholesterol crystals</span></p>"
        },
        {
          "id": 45892,
          "text": "<p><span style=\"font-size:12.0pt;\">High glucose</span></p>"
        },
        {
          "id": 45893,
          "text": "<p><span style=\"font-size:12.0pt;\">High LDH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following characteristics are found in the pleural effusion fluid of a rheumatoid arthritis patient except: (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q7891424",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290297,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) High Glucose</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rheumatoid pleural effusion, associated with rheumatoid arthritis, typically presents with low glucose levels, making high glucose the correct answer as it is not a characteristic found in such effusions. The low glucose in rheumatoid pleural effusion is due to increased metabolic activity of leukocytes and pleural cells which consume glucose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A. RA factor:&nbsp;</strong>The presence of RA factor (Rheumatoid factor) in pleural fluid is commonly seen in patients with rheumatoid arthritis. Rheumatoid factor is an autoantibody found in the blood of approximately 80% of adults with rheumatoid arthritis. Its presence in pleural fluid reflects the systemic inflammatory nature of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B. Cholesterol crystals:&nbsp;</strong>Cholesterol crystals in the pleural fluid are indicative of a long-standing effusion, which can occur in chronic rheumatoid pleuritis. These crystals form as the pleural fluid becomes more concentrated over time due to the chronic nature of the inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D. High LDH:&nbsp;</strong>High levels of lactate dehydrogenase (LDH) in the pleural fluid are a common feature of exudative effusions, including those caused by rheumatoid arthritis. LDH is an enzyme present in most cells and is released into the pleural fluid when cells are damaged or destroyed, reflecting the inflammatory processes occurring in rheumatoid pleuritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture47.jpg\" alt=\"\" width=\"500\" height=\"607\"></span></p>",
      "correct_choice_id": 45892,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54296,
      "choices": [
        {
          "id": 216653,
          "text": "<p><span style=\"font-size:12.0pt;\">Purulent conjunctivitis</span></p>"
        },
        {
          "id": 216654,
          "text": "<p><span style=\"font-size:12.0pt;\">Rash</span></p>"
        },
        {
          "id": 216655,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphadenopathy</span></p>"
        },
        {
          "id": 216656,
          "text": "<p><span style=\"font-size:12.0pt;\">Strawberry tongue</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which one is not a criterion for Kawasaki disease?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q1092164",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290298,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Purulent conjunctivitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Purulent conjunctivitis</strong> is not a criterion for Kawasaki disease. Instead, the conjunctivitis seen in Kawasaki disease is non-purulent and sterile, meaning it does not produce pus, and cultures are negative.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kawasaki disease is an acute, self-limited vasculitis that predominantly affects children. The diagnostic criteria for Kawasaki disease include the presence of fever for at least five days, along with at least four of the following five clinical features:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Bilateral non-purulent conjunctival injection (conjunctivitis):</strong> This is a common feature in Kawasaki disease, but it is non-purulent (does not produce pus).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Changes in the lips and oral cavity:</strong> This includes strawberry tongue (a red, bumpy tongue), erythema, and cracking of the lips.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Polymorphous rash:</strong> A rash of various forms can be present.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cervical lymphadenopathy:</strong> Typically unilateral and larger than 1.5 cm in diameter.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Changes in the extremities:</strong> This includes erythema of the palms and soles, edema of the hands and feet, and later desquamation (peeling) of the skin.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>TOC - IVIG (Intravenous Immunoglobulin) ±</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>Aspirin</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Rash:</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\">A polymorphous rash is one of the key diagnostic criteria for Kawasaki disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lymphadenopathy:</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\">Cervical lymphadenopathy is another diagnostic criterion, usually unilateral and larger than 1.5 cm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Strawberry tongue:</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\">Changes in the lips and oral cavity, including strawberry tongue, are diagnostic criteria for Kawasaki disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kawasaki disease is diagnosed based on a set of clinical criteria, including non-purulent conjunctivitis, rash, lymphadenopathy, and changes in the oral cavity such as strawberry tongue. Purulent conjunctivitis is not a feature of Kawasaki disease.</span></p>",
      "correct_choice_id": 216653,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11283,
      "choices": [
        {
          "id": 45098,
          "text": "<p><span style=\"font-size:12.0pt;\">TSH levels</span></p>"
        },
        {
          "id": 45099,
          "text": "<p><span style=\"font-size:12.0pt;\">C-peptide levels</span></p>"
        },
        {
          "id": 45100,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine sugar and ketone</span></p>"
        },
        {
          "id": 45101,
          "text": "<p><span style=\"font-size:12.0pt;\">IgA tissue transglutaminase antibody</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 15-year-old girl presented with fatigue, chronic diarrhea, weight loss, bone pain, and abdominal distension. Investigations revealed iron deficiency anemia and osteoporosis. Which of the following is the single best test to be done for her evaluation? (NEET PG 2020)</span></p>",
      "unique_key": "Q3256229",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290299,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. IgA tissue transglutaminase antibody</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">History is suggestive of chronic diarrhea with malabsorption occurring at the proximal small intestine (duodenum+ jejunum) causing protein loss (ascites, weight loss diarrhea), Osteoporosis (calcium, magnesium), and Iron deficiency (anemia).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">All above in a young patient should hint towards the possibility of celiac disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/24/nm38.jpg\" alt=\"\" width=\"500\" height=\"489\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. TSH levels:&nbsp;</strong>While important for evaluating thyroid function, symptoms of hypothyroidism can overlap with some celiac disease symptoms (like fatigue), but the gastrointestinal symptoms and specific nutrient deficiencies strongly point towards a primary gastrointestinal cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. C-peptide levels:&nbsp;</strong>C-peptide tests are used to evaluate insulin production levels and are more relevant in the context of diabetes management, not indicated here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Urine sugar and ketone:&nbsp;</strong>This test is used to diagnose and manage diabetes by detecting sugar and ketones in urine, not related to the suspected diagnosis of celiac disease based on the provided symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a young patient presenting with symptoms consistent with malabsorption, including gastrointestinal symptoms and specific nutrient deficiencies like iron and calcium, testing for celiac disease with an IgA tissue transglutaminase antibody test should be considered as a critical diagnostic step. This helps in confirming the diagnosis and facilitating appropriate dietary and medical management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21/Celiac disease/Chapter 325</strong></span></p>",
      "correct_choice_id": 45101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47640,
      "choices": [
        {
          "id": 190171,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumothorax</span></p>"
        },
        {
          "id": 190172,
          "text": "<p><span style=\"font-size:12.0pt;\">Consolidation</span></p>"
        },
        {
          "id": 190173,
          "text": "<p><span style=\"font-size:12.0pt;\">Collapse</span></p>"
        },
        {
          "id": 190174,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural effusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient came to emergency with severe breathlessness. CXR is taken and shown below. What is the diagnosis? (</span>FMGE Jan 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-112146.png\" alt=\"\" width=\"300\" height=\"257\"></span></p>",
      "unique_key": "Q7658351",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290300,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Pleural effusion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The chest X-ray (CXR) of the patient shows a whiteout on one side with a significant tracheal shift to the opposite side. These findings are indicative of a massive pleural effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Pleural effusion</strong>: This condition results in the accumulation of fluid in the pleural space, leading to lung compression and a shift of the mediastinum, including the trachea, away from the affected side. The presence of a large whiteout on the X-ray, along with the tracheal deviation to the opposite side, strongly suggests pleural effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pneumothorax</strong>: This condition would typically present with a hyperlucent (dark) area on the X-ray without lung markings, rather than a whiteout. It also generally causes a tracheal shift towards the opposite side, but the appearance on the X-ray would be different.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Consolidation</strong>: This condition involves filling of the alveoli with fluid or other material, leading to a whiteout appearance on the X-ray. However, it does not usually cause a significant tracheal shift.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Collapse</strong>: This condition, also known as atelectasis, would cause a shift of the trachea towards the affected side. It can present with a whiteout on the X-ray, but the tracheal deviation would be opposite to that seen in pleural effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A massive pleural effusion is characterized by a whiteout on the chest X-ray with a significant tracheal shift to the opposite side.</span></p>",
      "correct_choice_id": 190174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20265,
      "choices": [
        {
          "id": 81021,
          "text": "<p><span style=\"font-size:12.0pt;\">Basal cell carcinoma</span></p>"
        },
        {
          "id": 81022,
          "text": "<p><span style=\"font-size:12.0pt;\">Kaposi sarcoma</span></p>"
        },
        {
          "id": 81023,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant melanoma</span></p>"
        },
        {
          "id": 81024,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old HIV patient presented with a painful lesion, as shown in the image. What is the most likely diagnosis? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-30-170516.jpg\" alt=\"\" width=\"300\" height=\"303\"></span></p>",
      "unique_key": "Q6522920",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290301,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. Kaposi sarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kaposi sarcoma (KS) is a common malignancy in patients with HIV/AIDS. It is caused by human herpesvirus 8 (HHV-8) and typically presents as painless or painful, violaceous (purple) lesions on the skin and mucous membranes, including the oral cavity. The image shows such a lesion on the palate, which is characteristic of Kaposi sarcoma. These lesions are vascular in nature and can vary in color from red to purple, often with a raised or nodular appearance. In HIV patients, Kaposi sarcoma is an AIDS-defining condition and is often seen in those with significant immunosuppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Basal cell carcinoma:</strong> This type of skin cancer usually occurs in sun-exposed areas of the skin and rarely affects mucous membranes. It typically presents as a pearly or waxy bump, not as multiple purple lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Malignant melanoma:</strong> While melanomas can appear as pigmented lesions, they are usually black or brown and rarely present as multiple violaceous lesions in the oral cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Squamous cell carcinoma:</strong> This type of cancer can occur in the oral cavity but usually presents as a non-healing ulcer or a raised, firm, scaly plaque. It does not have the characteristic color and appearance of Kaposi sarcoma lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kaposi sarcoma should be suspected in HIV patients presenting with violaceous lesions on the skin or mucous membranes. It is an AIDS-defining condition associated with HHV-8 infection.</span></p>",
      "correct_choice_id": 81022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55402,
      "choices": [
        {
          "id": 221069,
          "text": "<p><span style=\"font-size:12pt;\">Neurofibromatosis</span></p>"
        },
        {
          "id": 221070,
          "text": "<p><span style=\"font-size:12pt;\">Tuberous sclerosis</span></p>"
        },
        {
          "id": 221071,
          "text": "<p><span style=\"font-size:12pt;\">Sturge-Weber syndrome</span></p>"
        },
        {
          "id": 221072,
          "text": "<p><span style=\"font-size:12pt;\">Von Hippel Lindau syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient presented with 2 Lisch nodules in the iris. What is the possible diagnosis? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q2993866",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290302,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Neurofibromatosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Lisch nodules are pigmented, benign hamartomas found in the iris of the eye. They are highly specific to Neurofibromatosis type 1 (NF1), also known as von Recklinghausen disease. NF1 is a genetic disorder characterized by the development of multiple benign tumors called neurofibromas, café-au-lait spots, and other neurological and ocular manifestations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Key diagnostic feature:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Lisch nodules:</strong> These are melanocytic hamartomas and are considered a hallmark of NF1. Their presence, particularly when there are two or more, is diagnostic of NF1.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Tuberous sclerosis:</strong> This genetic disorder is characterized by the growth of benign tumors in multiple organs, including the brain, skin, kidneys, and heart. It is associated with other ocular findings such as retinal hamartomas, but not with Lisch nodules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Sturge-Weber syndrome:</strong> This congenital disorder is associated with a port-wine stain birthmark, neurological abnormalities, and ocular issues like glaucoma, but not with Lisch nodules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Von Hippel Lindau syndrome:</strong> This is a genetic disorder that leads to the formation of tumors and cysts in different parts of the body, particularly the kidneys, pancreas, and central nervous system. It is not associated with Lisch nodules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The presence of Lisch nodules in the iris is highly specific for Neurofibromatosis type 1 (NF1), making it a key diagnostic feature for this condition</span></p>",
      "correct_choice_id": 221069,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11364,
      "choices": [
        {
          "id": 45422,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis</span></p>"
        },
        {
          "id": 45423,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis</span></p>"
        },
        {
          "id": 45424,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
        },
        {
          "id": 45425,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A male patient presents to the emergency department. The arterial blood gas report is as follows: pH 7.2, pCO2 81mm Hg, and HCO3 40 mEq/L. Which of the following is the most likely diagnosis? (Neet pg 2022)</span></p>",
      "unique_key": "Q3764416",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290303,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;C. Respiratory acidosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The arterial blood gas (ABG) report shows a pH of 7.2, which indicates acidosis (normal pH: 7.35-7.45). The partial pressure of carbon dioxide (pCO2) is elevated at 81 mm Hg (normal range: 35-45 mm Hg), indicating that the acidosis is due to a respiratory cause, as CO2 retention leads to respiratory acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The bicarbonate (HCO3) level is elevated at 40 mEq/L (normal range: 22-28 mEq/L). This elevation suggests that the kidneys are compensating for the respiratory acidosis by retaining bicarbonate to buffer the excess hydrogen ions, indicating a chronic component to the respiratory acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In summary, the primary disturbance is respiratory acidosis, evidenced by the elevated pCO2, and the elevated bicarbonate suggests a compensatory response by the kidneys, characteristic of chronic respiratory acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Respiratory alkalosis</strong>: Respiratory alkalosis is characterized by a high pH and low pCO2, which is the opposite of the findings in this ABG report.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Metabolic acidosis: </strong>Metabolic acidosis would present with a low pH and a low bicarbonate level. However, in this case, the bicarbonate is elevated, not decreased, indicating the primary issue is not metabolic acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Metabolic alkalosis: </strong>Metabolic alkalosis is characterized by a high pH and elevated bicarbonate, but without the accompanying high pCO2. The presence of high pCO2 and low pH indicates the primary disturbance is respiratory, not metabolic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A blood gas report showing low pH and high pCO2 with compensatory elevated bicarbonate indicates respiratory acidosis, often with a chronic component if the bicarbonate is significantly elevated.</span></p>",
      "correct_choice_id": 45424,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11537,
      "choices": [
        {
          "id": 46114,
          "text": "<p><span style=\"font-size:12.0pt;\">Metastatic breast cancer</span></p>"
        },
        {
          "id": 46115,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
        },
        {
          "id": 46116,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary hyperparathyroidism</span></p>"
        },
        {
          "id": 46117,
          "text": "<p><span style=\"font-size:12.0pt;\">Milk Alkali Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An elderly woman presented with symptoms of confusion, thirst, and abdominal pain. On examination, she had pallor and thoracic spine tenderness. X-ray spine showed osteolytic lesions. Her lab investigations showed the following findings: Hb - 6.9g/dL, WBC 4000/cm3 with normal differential count, Serum calcium 13mg/dL, Creatinine 2.3mg/dL, Total protein 9g/dL, Albumin 2.4g/dL. What is the most likely diagnosis? (INICET MAY 2021)</span></p>",
      "unique_key": "Q8043353",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290304,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B) Multiple myeloma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient's symptoms, combined with lab findings of anemia, hypercalcemia, elevated total protein, and low albumin, along with osteolytic lesions, are indicative of multiple myeloma. The <strong>CRAB criteria</strong> (hyperCalcemia, Renal failure, Anemia, and Bone lesions) support this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Metastatic breast cancer</strong> can present similarly but usually has a different primary site.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Primary hyperparathyroidism</strong> causes hypercalcemia but not the full CRAB criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Milk Alkali Syndrome</strong> causes hypercalcemia and renal impairment but not the protein abnormalities or osteolytic lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Multiple myeloma is characterized by anemia, hypercalcemia, renal failure, and bone lesions.</span></p>",
      "correct_choice_id": 46115,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20267,
      "choices": [
        {
          "id": 81029,
          "text": "<p><span style=\"font-size:12.0pt;\">HIV with disseminated histoplasmosis</span></p>"
        },
        {
          "id": 81030,
          "text": "<p><span style=\"font-size:12.0pt;\">HIV with disseminated cryptococcosis</span></p>"
        },
        {
          "id": 81031,
          "text": "<p><span style=\"font-size:12.0pt;\">HIV with molluscum contagiosum</span></p>"
        },
        {
          "id": 81032,
          "text": "<p><span style=\"font-size:12.0pt;\">HIV with tuberculosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old HIV-positive male came with complaints of persistent cough and weight loss. He has skin lesions as shown in the image. Chest x-ray showed multiple bilateral nodular infiltrates. His sputum CBNAAT for tuberculosis was negative and he has a low CD4 count. What is the probable diagnosis? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-30-170533.jpg\" alt=\"\" width=\"300\" height=\"193\"></span></p>",
      "unique_key": "Q4719489",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290305,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. HIV with disseminated histoplasmosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, the patient presents with persistent cough, weight loss, and skin lesions. The chest x-ray reveals multiple bilateral nodular infiltrates, and the patient has a low CD4 count. These findings are significant for several reasons:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Disseminated histoplasmosis</strong> can mimic tuberculosis, especially in HIV-positive patients. It causes disseminated disease with pulmonary involvement (multiple bilateral nodular infiltrates) and skin lesions. The presence of these lesions and a negative sputum CBNAAT for tuberculosis further supports histoplasmosis, as this fungal infection is common in immunocompromised individuals with low CD4 counts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. HIV with disseminated cryptococcosis</strong>: While cryptococcosis can cause lung disease, it more commonly presents with central nervous system involvement, such as meningitis or meningoencephalitis. This patient does not exhibit neurological symptoms, making cryptococcosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. HIV with molluscum contagiosum</strong>: Molluscum contagiosum causes umbilicated papules but does not lead to bilateral nodular infiltrates in the lungs. Thus, this diagnosis is unlikely given the chest x-ray findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. HIV with tuberculosis</strong>: Tuberculosis is a common infection in HIV-positive patients and can present with similar symptoms and radiographic findings. However, the negative sputum CBNAAT for tuberculosis makes this diagnosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educaitonal Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Disseminated histoplasmosis in HIV-positive patients can mimic tuberculosis, presenting with pulmonary nodular infiltrates and skin lesions, especially in those with low CD4 counts.</span></p>",
      "correct_choice_id": 81029,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24775,
      "choices": [
        {
          "id": 99061,
          "text": "<p><span style=\"font-size:11.0pt;\">25</span></p>"
        },
        {
          "id": 99062,
          "text": "<p><span style=\"font-size:11.0pt;\">68</span></p>"
        },
        {
          "id": 99063,
          "text": "<p><span style=\"font-size:11.0pt;\">35</span></p>"
        },
        {
          "id": 99064,
          "text": "<p><span style=\"font-size:11.0pt;\">43</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient with chronic kidney disease has the following laboratory reports. Calculate the anion gap in this patient. Na<sup>+</sup>: 145 mEq/L, K<sup>+</sup> 4 mEq/L Cl: 90 mEq/L HCO3: 20 mEq/L. (INICET MAY 2023)</span></p>",
      "unique_key": "Q9165858",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290306,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C)&nbsp;35</strong></span></p><p><br><span style=\"font-size:12pt;\">The anion gap is calculated using the formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anion&nbsp;Gap = Na−(Cl+HCO3)</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">Anion&nbsp;Gap=145−(90+20)=35</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The anion gap is calculated as Na - (Cl + HCO3), and a high anion gap may indicate metabolic acidosis.</span></p>",
      "correct_choice_id": 99063,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16169,
      "choices": [
        {
          "id": 64636,
          "text": "<p><span style=\"font-size:12.0pt;\">G6PD deficiency</span></p>"
        },
        {
          "id": 64637,
          "text": "<p><span style=\"font-size:12.0pt;\">Paroxysmal nocturnal hemoglobinuria</span></p>"
        },
        {
          "id": 64638,
          "text": "<p><span style=\"font-size:12.0pt;\">Hereditary spherocytosis</span></p>"
        },
        {
          "id": 64639,
          "text": "<p><span style=\"font-size:12.0pt;\">Hairy cell leukemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Elective splenectomy is preferred in which of the following conditions? (FMGE JAN 2023)</span></p>",
      "unique_key": "Q2811393",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290307,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;C) Hereditary spherocytosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Why Hereditary Spherocytosis is Correct:&nbsp;</strong>Hereditary spherocytosis is a condition characterized by the presence of spherical red blood cells that are prone to hemolysis. The spleen plays a significant role in the destruction of these abnormal red blood cells. <strong>Splenectomy is the treatment of choice</strong> for hereditary spherocytosis because it reduces hemolysis and anemia, leading to an improvement in the patient’s quality of life. It is typically recommended for patients with severe hemolysis or those who are transfusion-dependent.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Most Common Defect:&nbsp;</strong>The most common defect in hereditary spherocytosis is in the <strong>ankyrin protein.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Diagnostic Test:&nbsp;</strong>The investigation of choice for confirming hereditary spherocytosis is <strong>flow cytometry with</strong> <strong>eosin-5-maleimide</strong>. Historically, the osmotic fragility test was used.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Timing of Splenectomy:&nbsp;</strong>Splenectomy is generally performed <strong>after the age of 6 years</strong> and is <strong>indicated in patients with transfusion dependency anemia</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>(majorly), severe anemia or growth retardation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. G6PD deficiency:</strong> G6PD deficiency causes hemolysis primarily due to oxidative stress. Splenectomy is not beneficial because the spleen is not the primary site of red cell destruction in this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Paroxysmal nocturnal hemoglobinuria (PNH):</strong> PNH involves intravascular hemolysis due to a defect in the red cell membrane. Splenectomy is not useful as the spleen is not involved in the hemolytic process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hairy cell leukemia:</strong> While splenectomy can sometimes be part of the management for symptomatic splenomegaly in hairy cell leukemia, it is not typically the first-line treatment. The primary treatment involves chemotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Elective splenectomy is indicated in hereditary spherocytosis to decrease hemolysis and improve symptoms, particularly in patients with severe anemia or those who require frequent blood transfusions.</span></p>",
      "correct_choice_id": 64638,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11483,
      "choices": [
        {
          "id": 45898,
          "text": "<p><span style=\"font-size:12.0pt;\">Shrinking lung syndrome</span></p>"
        },
        {
          "id": 45899,
          "text": "<p><span style=\"font-size:12.0pt;\">Intra alveolar hemorrhage</span></p>"
        },
        {
          "id": 45900,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleuritis with/without pleural effusion</span></p>"
        },
        {
          "id": 45901,
          "text": "<p><span style=\"font-size:12.0pt;\">Interstitial inflammation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most common pulmonary manifestation of SLE? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q6507467",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290308,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Pleuritis with/without pleural effusion.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pleuritis with or without pleural effusion is the most common pulmonary manifestation in patients with SLE. This condition reflects the systemic inflammatory nature of SLE, which frequently affects serous membranes including the pleura. Pleural involvement in SLE typically presents as an exudative pleural effusion, often characterized by pleuritic pain and effusion that can be detected by physical examination and imaging studies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture48.jpg\" alt=\"\" width=\"1000\" height=\"1015\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Shrinking lung syndrome:&nbsp;</strong>is very rare occurring in 1% of patients. Some association with <strong>Anti-Ro/La antibodies seen</strong>. No correlation between disease activity, symptoms and antibodies.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>B. Intra Alveolar hemorrhage and D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Interstitial inflammation:&nbsp;</strong>are not the most common presentation.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pleuritis with or without pleural effusion stands out as the most frequent pulmonary complication in SLE due to the disease’s propensity to inflame serous membranes. Accurate diagnosis and effective management of SLE and its pulmonary manifestations are crucial for improving quality of life and reducing morbidity in affected patients.</span></p>",
      "correct_choice_id": 45900,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11284,
      "choices": [
        {
          "id": 45102,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis</span></p>"
        },
        {
          "id": 45103,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis</span></p>"
        },
        {
          "id": 45104,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis</span></p>"
        },
        {
          "id": 45105,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old male presented with tachypnea and mental confusion. His blood sugar is 350 mg/dL, pH - 7.2, HCO3- 10 mEq/L, pCO2 – 25 mmHg. What is the metabolic abnormality? (NEET PG 2020)</span></p>",
      "unique_key": "Q4835768",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290309,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Metabolic acidosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with a significantly acidic pH (7.2) and a low bicarbonate level (HCO3- = 10 mEq/L), indicating metabolic acidosis. The pCO2 is also reduced (25 mmHg), which suggests a respiratory compensatory mechanism aiming to increase acid excretion (by hyperventilating to blow off CO2) to counterbalance the acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This presentation is consistent with diabetic ketoacidosis (DKA), a common complication of diabetes that leads to metabolic acidosis, elevated blood glucose, and electrolyte imbalances due to the production of ketoacids from the breakdown of fats. The high blood sugar level of 350 mg/dL supports this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Metabolic alkalosis:&nbsp;</strong>Incorrect as the low HCO3- and acidic pH point to acidosis, not alkalosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Respiratory alkalosis:&nbsp;</strong>Incorrect as the low pCO2 is a compensatory response to the metabolic acidosis, not the primary disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Respiratory acidosis:&nbsp;</strong>Incorrect as this would involve an elevated pCO2, opposite of what is observed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the presence of high blood sugar and the reported ABG values, metabolic acidosis, particularly diabetic ketoacidosis, should be considered. This condition requires prompt recognition and management, typically involving fluid resuscitation, insulin therapy, and electrolyte management to reverse the ketosis and acidosis.</span></p>",
      "correct_choice_id": 45103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47641,
      "choices": [
        {
          "id": 190175,
          "text": "<p><span style=\"font-size:12.0pt;\">Melanocyte Stimulating Hormone (MSH)</span></p>"
        },
        {
          "id": 190176,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemosiderin</span></p>"
        },
        {
          "id": 190177,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuropeptide Y</span></p>"
        },
        {
          "id": 190178,
          "text": "<p><span style=\"font-size:12.0pt;\">Melanin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A chronic smoker presented with weight gain and hyperpigmentation of palms and soles. He was subsequently diagnosed to have lung cancer. Which of the following is responsible for hyperpigmentation? (</span>FMGE Jan 2024)</p>",
      "unique_key": "Q1253225",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290310,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Melanocyte Stimulating Hormone (MSH)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient, a chronic smoker, presented with weight gain and hyperpigmentation of the palms and soles and was diagnosed with lung cancer. This clinical scenario suggests the presence of an ectopic ACTH-producing tumor, most commonly associated with small cell lung cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In such cases, the excessive ACTH produced by the tumor can lead to Cushing's syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Additionally, ACTH has an intrinsic MSH (Melanocyte Stimulating Hormone) activity due to the shared precursor molecule, proopiomelanocortin (POMC). The MSH part within ACTH stimulates melanocytes, leading to increased melanin production and resulting in hyperpigmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hemosiderin</strong>: Hemosiderin is an iron-storage complex. It does not play a role in causing hyperpigmentation in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Neuropeptide Y</strong>: Neuropeptide Y is involved in various physiological processes, including regulation of appetite and stress responses, but not in causing hyperpigmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Melanin</strong>: While melanin is the pigment responsible for skin color, its production is stimulated by MSH. Thus, MSH is the direct cause of increased melanin and subsequent hyperpigmentation in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of ectopic ACTH production, such as with small cell lung cancer, hyperpigmentation occurs due to the MSH activity of ACTH, which stimulates melanocytes to produce melanin.</span></p>",
      "correct_choice_id": 190175,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55403,
      "choices": [
        {
          "id": 221073,
          "text": "<p><span style=\"font-size:12pt;\">Acute Bacterial Meningitis</span></p>"
        },
        {
          "id": 221074,
          "text": "<p><span style=\"font-size:12pt;\">Viral Meningitis</span></p>"
        },
        {
          "id": 221075,
          "text": "<p><span style=\"font-size:12pt;\">TB Meningitis</span></p>"
        },
        {
          "id": 221076,
          "text": "<p><span style=\"font-size:12pt;\">Fungal Meningitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 34-year-old patient presented with fever, headache, vomiting, and neck stiffness. Lumbar puncture was performed, and the reports are as follows: (FMGE JULY 2024)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Opening pressure – elevated</span></li><li><span style=\"font-size:12pt;\">Appearance – cloudy</span></li><li><span style=\"font-size:12pt;\">Cell count – 80 (70% PMNs)</span></li><li><span style=\"font-size:12pt;\">Sugar – 35 mg/dL</span></li><li><span style=\"font-size:12pt;\">Protein – 200 mg/dL</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">What is the likely diagnosis?</span></p>",
      "unique_key": "Q7937137",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290311,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Acute Bacterial Meningitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient presents with symptoms suggestive of meningitis: fever, headache, vomiting, and neck stiffness. The cerebrospinal fluid (CSF) analysis from the lumbar puncture provides several key clues:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Elevated opening pressure, which is common in bacterial meningitis.</span></li><li><span style=\"font-size:12pt;\">Cloudy appearance of the CSF, indicating a high number of cells or increased protein.</span></li><li><span style=\"font-size:12pt;\">Cell count of 80 with 70% polymorphonuclear leukocytes (PMNs), which is highly indicative of bacterial infection as it typically shows a neutrophilic predominance.</span></li><li><span style=\"font-size:12pt;\">Low glucose level (35 mg/dL) and elevated protein level (200 mg/dL), which are consistent with bacterial meningitis due to the consumption of glucose by bacteria and increased protein from the inflammatory process.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Viral Meningitis: </strong>Viral meningitis usually presents with a lymphocytic predominance in the CSF, normal or slightly elevated protein, and normal glucose levels. This does not match the neutrophil predominance and low glucose levels seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C</strong>. <strong>TB Meningitis: </strong>TB meningitis often shows a lymphocytic predominance in the CSF, significantly elevated protein levels, and moderately low glucose levels. While the glucose and protein levels could fit, the neutrophil predominance makes TB meningitis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Fungal Meningitis: </strong>Fungal meningitis typically presents with a mixed or lymphocytic predominance in the CSF, elevated protein, and low glucose. Neutrophilic predominance is not characteristic of fungal meningitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Acute bacterial meningitis is characterized by elevated opening pressure, cloudy CSF, a high cell count with neutrophilic predominance, low glucose, and elevated protein levels in the CSF.</span></p>",
      "correct_choice_id": 221073,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11538,
      "choices": [
        {
          "id": 46118,
          "text": "<p><span style=\"font-size:12.0pt;\">Test for ANCA</span></p>"
        },
        {
          "id": 46119,
          "text": "<p><span style=\"font-size:12.0pt;\">Biopsy to show granulomas</span></p>"
        },
        {
          "id": 46120,
          "text": "<p><span style=\"font-size:12.0pt;\">AFB staining of sputum</span></p>"
        },
        {
          "id": 46121,
          "text": "<p><span style=\"font-size:12.0pt;\">BAL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with sinusitis, ulcerative lesions on the nasopharynx, nodular lesions with cavitations of the lung, and renal failure. Which of the following is the most useful investigation in this patient? (INICET MAY 2021)</span></p>",
      "unique_key": "Q9993310",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290312,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;A) Test for ANCA</strong></span></p><p><br><span style=\"font-size:12pt;\">The clinical presentation of ENT involvement, lung nodules with cavitations, and renal failure suggests granulomatosis with polyangiitis (GPA). The ANCA (anti-neutrophil cytoplasmic antibodies) test is a useful diagnostic tool for GPA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:12pt;\"><strong>Option B. Biopsy to show granulomas</strong> is useful but more invasive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. AFB staining of sputum</strong> is for TB, not GPA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. BAL (bronchoalveolar lavage):&nbsp;</strong> is not specific for diagnosing GPA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In suspected GPA, the ANCA test is the most useful initial investigation.</span></p>",
      "correct_choice_id": 46118,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11286,
      "choices": [
        {
          "id": 45110,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickle cell anemia</span></p>"
        },
        {
          "id": 45111,
          "text": "<p><span style=\"font-size:12.0pt;\">Malaria</span></p>"
        },
        {
          "id": 45112,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancreatitis</span></p>"
        },
        {
          "id": 45113,
          "text": "<p><span style=\"font-size:12.0pt;\">Measles</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A ten-year-old boy was brought to the OPD with fever and swelling of hands after playing football. He gives a history of previous episodes of swelling of hands. On imaging, his spleen was found to be shrunken. Which of the following is a likely diagnosis? (NEET PG 2020)</span></p>",
      "unique_key": "Q9847838",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290313,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Sickle cell anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">History is suggestive of dactylitis precipitated by playing <strong>causing microvascular obstruction</strong>. Shrunken spleen suggestive of auto splenectomy with recurrent episodes of dactylitis suggests sickle cell anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Malaria:&nbsp;</strong>Typically presents with cyclical fever, chills, and splenomegaly rather than a shrunken spleen. The history of recurrent hand swelling isn't typical for malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C. Pancreatitis:</strong> Main symptoms include severe abdominal pain, nausea, and vomiting, unrelated to the symptoms described in the case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Measles:&nbsp;</strong>Characterized by a rash, fever, cough, conjunctivitis, and Koplik spots, none of which relate to the symptoms described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a child presenting with fever and recurrent hand swelling following physical activity, alongside a history of a shrunken spleen, sickle cell anemia should be considered a primary diagnosis. This highlights the importance of considering hemoglobinopathies in patients with peculiar skeletal pains and organ findings suggestive of chronic hemolytic processes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21 /Hemoglobinopathies/Chapter 98</strong></span></p>",
      "correct_choice_id": 45110,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47642,
      "choices": [
        {
          "id": 190179,
          "text": "<p><span style=\"font-size:12.0pt;\">QT prolongation</span></p>"
        },
        {
          "id": 190180,
          "text": "<p><span style=\"font-size:12.0pt;\">PR prolongation</span></p>"
        },
        {
          "id": 190181,
          "text": "<p><span style=\"font-size:12.0pt;\">ST elevation</span></p>"
        },
        {
          "id": 190182,
          "text": "<p><span style=\"font-size:12.0pt;\">Wide QRS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the likely ECG change associated with Bedaquiline?</span></p>",
      "unique_key": "Q7842035",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290314,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) QT prolongation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bedaquiline is a modern anti-tubercular drug used primarily for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis. One of the significant side effects of bedaquiline is QT prolongation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">QT prolongation is a measure of delayed ventricular repolarization, which can be seen on an ECG as an extended QT interval. This side effect is critical as it can predispose patients to potentially fatal arrhythmias, such as Torsades de Pointes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. PR prolongation</strong>: This represents delayed atrioventricular conduction and is not a known side effect of bedaquiline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. ST elevation</strong>: This is typically associated with myocardial infarction and is not a side effect of bedaquiline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Wide QRS</strong>: This indicates delayed intraventricular conduction and is not associated with bedaquiline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bedaquiline, an important drug for treating MDR and XDR tuberculosis, is known for causing QT prolongation on ECG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note -</strong> <strong>The \"Q\" in bedaquiline can be a mnemonic to remember this important side effect.</strong></span></p>",
      "correct_choice_id": 190179,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55404,
      "choices": [
        {
          "id": 221077,
          "text": "<p><span style=\"font-size:12pt;\">Ibuprofen</span></p>"
        },
        {
          "id": 221078,
          "text": "<p><span style=\"font-size:12pt;\">Sumatriptan</span></p>"
        },
        {
          "id": 221079,
          "text": "<p><span style=\"font-size:12pt;\">Propranolol</span></p>"
        },
        {
          "id": 221080,
          "text": "<p><span style=\"font-size:12pt;\">Verapamil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 58-year-old hypertensive patient with a history of myocardial infarction (MI) presents with an acute attack of migraine. Which of the following medications should not be given?<strong> </strong>(FMGE JULY 2024)</span></p>",
      "unique_key": "Q1086541",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290315,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Sumatriptan</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sumatriptan is a medication used to treat acute migraine attacks and works as a selective serotonin receptor agonist (<strong>5-HT1B/1D receptor agonist</strong>). However, it is contraindicated in patients with a history of coronary artery disease (CAD) or other significant cardiovascular diseases, including previous myocardial infarction (MI). This is because sumatriptan can cause <strong>vasoconstriction</strong>, which can exacerbate these conditions, leading to serious cardiovascular events.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A</strong>. <strong>Ibuprofen:&nbsp;</strong> A nonsteroidal anti-inflammatory drug (NSAID) that can be used to treat migraine pain. It does not have the same cardiovascular risks as triptans and can be safely used in patients with a history of MI, although caution is advised in hypertensive patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> <strong>Propranolol:&nbsp;</strong> A beta-blocker often used for migraine prophylaxis. It is actually beneficial for patients with a history of MI as it reduces the risk of further cardiac events by lowering heart rate and blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Verapamil: </strong>A calcium channel blocker that is sometimes used for migraine prevention. It is generally safe for use in patients with a history of MI and can help manage hypertension as well.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sumatriptan, a vasoconstrictor, should not be given to patients with a history of coronary artery disease or myocardial infarction due to the risk of triggering serious cardiovascular events.</span></p>",
      "correct_choice_id": 221078,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11292,
      "choices": [
        {
          "id": 45134,
          "text": "<p><span style=\"font-size:12.0pt;\">Kerley B lines</span></p>"
        },
        {
          "id": 45135,
          "text": "<p><span style=\"font-size:12.0pt;\">Focal oligemia</span></p>"
        },
        {
          "id": 45136,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased venous blood in lung</span></p>"
        },
        {
          "id": 45137,
          "text": "<p><span style=\"font-size:12.0pt;\">Change in upper lobe circulation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a radiological finding in a patient with left heart failure? (NEET PG 2020)</span></p>",
      "unique_key": "Q4400520",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290386,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Focal oligemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Focal oligemia, also known as the Westermark sign, is a radiological finding indicative of pulmonary embolism, not heart failure. It represents a regional reduction in lung vascularity and is seen on chest radiographs as an area of decreased blood flow and enhanced clarity due to vascular obstruction from a clot.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Radiological Findings in Left Heart Failure:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Kerley B lines:&nbsp;</strong>These are thin linear opacities caused by interstitial edema, especially near the lung bases, and are commonly associated with congestive heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increased venous blood in lung:&nbsp;</strong>Also known as pulmonary venous hypertension, this finding is due to increased pressure in the pulmonary veins that results from left heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Change in upper lobe circulation:&nbsp;</strong>This refers to the redistribution of blood flow to the upper lobes, a classic sign of pulmonary venous hypertension seen in left heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Further Stages of Left Heart Failure on CXR:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Stage 1 (PCWP 13-18 mmHg):&nbsp;</strong>Cardiomegaly, redistribution of pulmonary vessels, broad vascular pedicle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stage 2 (PCWP 18-25 mmHg):&nbsp;</strong>Kerley B lines and peribronchial cuffing indicating interstitial edema.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stage 3 (PCWP &gt; 25 mmHg):&nbsp;</strong>Alveolar edema leading to consolidation and pleural effusion.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In patients with suspected heart failure, radiological findings such as Kerley B lines, increased pulmonary venous pressure, and altered upper lobe circulation are indicative. Focal oligemia, however, suggests a differential diagnosis of pulmonary embolism and should prompt further investigation for this condition rather than heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/24/screenshot-2024-07-24-114523.jpg\" alt=\"\" width=\"929\" height=\"740\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Radiology assistant/ CXR in heart failure</strong></span></p>",
      "correct_choice_id": 45135,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66677,
      "choices": [
        {
          "id": 265845,
          "text": "<p><span style=\"font-size:12.0pt;\">Acyclovir&nbsp;</span></p>"
        },
        {
          "id": 265846,
          "text": "<p><span style=\"font-size:12.0pt;\">Corticosteroids&nbsp;</span></p>"
        },
        {
          "id": 265847,
          "text": "<p><span style=\"font-size:12.0pt;\">Antibiotics&nbsp;</span></p>"
        },
        {
          "id": 265848,
          "text": "<p><span style=\"font-size:12.0pt;\">Physiotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old patient presented with right facial weakness and painful vesicular eruptions in the external auditory canal. Routine lab workup was normal. What is the next best step in management? [Twisted PYQ</span></p>",
      "unique_key": "Q6567591",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290387,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Acyclovir</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presentation suggests Ramsay Hunt syndrome (herpes zoster oticus) characterized by:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Facial weakness</span></li><li><span style=\"font-size:12.0pt;\">Vesicular eruptions in external ear</span></li><li><span style=\"font-size:12.0pt;\">Associated with VZV reactivation</span></li><li><span style=\"font-size:12.0pt;\">Higher risk of permanent nerve damage than Bell's palsy</span></li><li><span style=\"font-size:12.0pt;\">Requires prompt antiviral therapy</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Early initiation of antivirals is crucial as it:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Reduces viral replication</span></li><li><span style=\"font-size:12.0pt;\">Prevents further nerve damage</span></li><li><span style=\"font-size:12.0pt;\">Improves recovery outcomes</span></li><li><span style=\"font-size:12.0pt;\">Reduces post-herpetic neuralgia risk</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Corticosteroids</strong>: While useful, they should be given in combination with antivirals, not alone, as this is a confirmed viral etiology.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Antibiotics</strong>: Not indicated as this is a viral condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Physiotherapy</strong>: Supportive therapy only, not the primary treatment needed for active viral infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Recognition of Ramsay Hunt syndrome features</span></li><li><span style=\"font-size:12.0pt;\">Understanding the importance of early antiviral therapy</span></li><li><span style=\"font-size:12.0pt;\">Differentiating from Bell's palsy</span></li><li><span style=\"font-size:12.0pt;\">Knowledge of appropriate management sequence</span></li></ol>",
      "correct_choice_id": 265845,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47643,
      "choices": [
        {
          "id": 190183,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypokalemia</span></p>"
        },
        {
          "id": 190184,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperkalemia</span></p>"
        },
        {
          "id": 190185,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypocalcemia</span></p>"
        },
        {
          "id": 190186,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypophosphatemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following electrolyte abnormalities are seen in Refeeding Syndrome except: (</span>FMGE Jan 2024)</p>",
      "unique_key": "Q6705368",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290388,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hyperkalemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Refeeding syndrome occurs when nutrients are reintroduced to a severely malnourished patient, leading to metabolic and electrolyte disturbances. The reintroduction of carbohydrates causes an insulin surge, which drives electrolytes into cells, resulting in the following abnormalities:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Hypokalemia</strong>: Potassium is driven into cells, lowering serum levels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hypophosphatemia</strong>: Phosphate is used up in the production of ATP, lowering serum levels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hypocalcemia</strong>: Increased cellular uptake of calcium can lower serum levels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These hypoelectrolyte states are critical to monitor as they can lead to severe complications such as cardiac arrhythmias, muscle weakness, and respiratory failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option &nbsp;A.&nbsp; Hypokalemia</strong>: This is not seen in refeeding syndrome. Instead, refeeding syndrome typically results in hypokalemia due to the intracellular shift of potassium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hypocalcemia</strong>: Seen due to the cellular uptake of calcium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hypophosphatemia</strong>: A hallmark of refeeding syndrome, driven by increased cellular utilization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Refeeding syndrome is characterized by multiple hypoelectrolyte abnormalities, including hypokalemia, hypophosphatemia, and hypocalcemia, but not hyperkalemia.</span></p>",
      "correct_choice_id": 190184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55405,
      "choices": [
        {
          "id": 221081,
          "text": "<p><span style=\"font-size:12pt;\">Delirium tremens</span></p>"
        },
        {
          "id": 221082,
          "text": "<p><span style=\"font-size:12pt;\">Wernicke Encephalopathy</span></p>"
        },
        {
          "id": 221083,
          "text": "<p><span style=\"font-size:12pt;\">Korsakoff Psychosis</span></p>"
        },
        {
          "id": 221084,
          "text": "<p><span style=\"font-size:12pt;\">Withdrawal seizures</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A chronic alcoholic came with complaints of agitation, disorientation, hallucination, fever, hypertension, and diaphoresis after stopping alcohol intake for 48 hours. Which of the following is the diagnosis? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q3076640",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290389,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Delirium tremens</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Delirium tremens (DT) is a severe form of alcohol withdrawal that usually occurs 48 to 96 hours after cessation of heavy, prolonged alcohol use. It is characterized by agitation, disorientation, hallucinations, fever, hypertension, and diaphoresis, which indicate autonomic instability. Delirium tremens is a medical emergency and can be life-threatening without appropriate treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The <strong>first-line treatment</strong> for delirium tremens is <strong>benzodiazepines, particularly diazepam.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In patients with liver cirrhosis, shorter-acting benzodiazepines like oxazepam, temazepam, or lorazepam are preferred due to their safer profile in hepatic impairment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Wernicke Encephalopathy:</strong> This condition is characterized by confusion, ataxia, and ophthalmoplegia due to thiamine deficiency but does not typically present with autonomic instability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Korsakoff Psychosis:</strong> This is a chronic memory disorder caused by severe thiamine deficiency, often seen in chronic alcoholism, but it does not present with the acute autonomic instability seen in delirium tremens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Withdrawal seizures:</strong> These can occur within 6 to 48 hours after alcohol cessation but are not associated with the severe autonomic instability and other symptoms of delirium tremens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Delirium tremens is a <strong>severe, life-threatening</strong> form of alcohol withdrawal that occurs 48 to 96 hours after cessation of alcohol intake, characterized by autonomic instability, agitation, disorientation, and hallucinations. The first-line treatment is benzodiazepines, particularly diazepam.</span></p>",
      "correct_choice_id": 221081,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47638,
      "choices": [
        {
          "id": 190163,
          "text": "<p><span style=\"font-size:12.0pt;\">1 aerobic and 1 anaerobic</span></p>"
        },
        {
          "id": 190164,
          "text": "<p><span style=\"font-size:12.0pt;\">3 samples - 1 aerobic, 2 anaerobic</span></p>"
        },
        {
          "id": 190165,
          "text": "<p><span style=\"font-size:12.0pt;\">3 samples - 2 aerobic and 1 anaerobic</span></p>"
        },
        {
          "id": 190166,
          "text": "<p><span style=\"font-size:12.0pt;\">3 aerobic and 3 anaerobic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">How will you collect samples for blood culture in a patient with suspected Infective Endocarditis?</span></p>",
      "unique_key": "Q6968148",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290390,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 3 aerobic and 3 anaerobic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Infective endocarditis is diagnosed using <strong>Duke's criteria</strong>, which includes major and minor criteria. One of the major criteria involves positive blood cultures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For accurate diagnosis, it is essential to collect multiple blood cultures to identify the causative organism reliably.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A blood <strong>culture set</strong> includes both aerobic and anaerobic samples.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to Duke's criteria:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>A minimum of two cultures should be drawn at least 12 hours apart.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Ideally, three or more cultures should be collected.</strong></span></li><li><span style=\"font-size:12.0pt;\">When collecting three or more cultures, each culture set includes both aerobic and anaerobic samples.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, for three culture sets, you would collect three aerobic and three anaerobic samples.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The rules for collection are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">If two culture sets are collected, both should be drawn at least 12 hours apart and both should be positive.</span></li><li><span style=\"font-size:12.0pt;\">If three or more culture sets are collected, all three should be positive for the same organism.</span></li><li><span style=\"font-size:12.0pt;\">If more than three culture sets are collected, the majority should be positive for the same organism.</span></li><li><span style=\"font-size:12.0pt;\"><strong>The gap between the first and the last culture should be at least one hour.</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For suspected infective endocarditis, the recommended blood culture collection includes three aerobic and three anaerobic samples to ensure accurate diagnosis and identification of the causative organism</span></p>",
      "correct_choice_id": 190166,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55400,
      "choices": [
        {
          "id": 221061,
          "text": "<p><span style=\"font-size:12pt;\">EMG</span></p>"
        },
        {
          "id": 221062,
          "text": "<p><span style=\"font-size:12pt;\">CT scan chest</span></p>"
        },
        {
          "id": 221063,
          "text": "<p><span style=\"font-size:12pt;\">Acetylcholinesterase test</span></p>"
        },
        {
          "id": 221064,
          "text": "<p><span style=\"font-size:12pt;\">Nerve conduction velocity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 30-year-old woman complains of ptosis and diplopia that worsens with activity and improves with rest. What is the most sensitive investigation? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q7589689",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290391,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) EMG (Electromyography)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The symptoms of ptosis and diplopia that worsen with activity and improve with rest are characteristic of myasthenia gravis, a neuromuscular disorder caused by autoimmune destruction of acetylcholine receptors at the neuromuscular junction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most sensitive investigation for myasthenia gravis is <strong>single fiber</strong> <strong>electromyography </strong>(SF-EMG), which detects abnormalities in the neuromuscular transmission by measuring the electrical activity of muscle fibers. Even if single fiber EMG is not specifically mentioned, standard EMG is still highly sensitive and appropriate for diagnosing myasthenia gravis. Another practical test used is repetitive nerve stimulation (RNS), which shows a decremental response in myasthenia gravis patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. CT scan chest:</strong> This is usually performed in confirmed myasthenia gravis patients to rule out thymoma, but it is not the most sensitive test for diagnosing the condition itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Acetylcholinesterase test:</strong> Also known as the edrophonium test or Tensilon test, this can be used to diagnose myasthenia gravis by temporarily improving muscle strength. However, it has variable sensitivity and specificity and is less sensitive than EMG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Nerve conduction velocity:</strong> This test is more relevant in the diagnosis of neuropathies, particularly demyelinating neuropathies, where conduction velocities are decreased. It is not the most sensitive test for myasthenia gravis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most sensitive investigation for diagnosing myasthenia gravis is electromyography (EMG), particularly single fiber EMG, which detects abnormalities in neuromuscular transmission.</span></p>",
      "correct_choice_id": 221061,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11714,
      "choices": [
        {
          "id": 46822,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis</span></p>"
        },
        {
          "id": 46823,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis</span></p>"
        },
        {
          "id": 46824,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis</span></p>"
        },
        {
          "id": 46825,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient of hemophilia received multiple blood transfusions. Which of the following metabolic abnormalities can be seen in a patient? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q5985782",
      "question_audio": null,
      "question_video": null,
      "map_id": 16290392,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Metabolic Alkalosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metabolic alkalosis in a patient who received multiple blood transfusions arises primarily from the metabolism of citrate, used as a preservative in stored blood products.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Massive transfusion (MT) is defined as the replacement by transfusion of <i>10 units of pRBCs </i>in 24 hours or more than <i>4 units of pRBCs</i> in one hour.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Excess citrate preservative gets converted to bicarbonate causing Metabolic alkalosis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Metabolic Acidosis:&nbsp;</strong>This condition would typically result from an accumulation of acids or loss of bicarbonate, which is not a direct consequence of blood transfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Respiratory Alkalosis:&nbsp;</strong>Would involve hyperventilation leading to decreased carbon dioxide levels, unrelated to transfusion effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Respiratory Acidosis:&nbsp;</strong>Involves hypoventilation increasing carbon dioxide levels, which is also unrelated to the effects of blood transfusions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metabolic alkalosis is a potential complication of multiple or massive blood transfusions due to the metabolism of citrate preservative into bicarbonate, emphasizing the importance of monitoring electrolytes and acid-base balance during such procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/11/whatsapp-image-2024-09-11-at-101953-am.jpeg\" alt=\"\" width=\"1000\" height=\"1171\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/11/whatsapp-image-2024-09-11-at-101953-am-1.jpeg\" alt=\"\" width=\"1000\" height=\"694\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Delayed complications:&nbsp;</u></strong>GVHD, PTP, Infections</span></p>",
      "correct_choice_id": 46822,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}